{
    "abstract": " Background: We estimated the relative efficacy and safety of vaccines for prevention of herpes zoster (HZ) using network meta-analysis (NMA) based on evidence from randomized controlled trials. Methods: A systematic literature review evaluated two different HZ vaccines: adjuvanted recombinant zoster vaccine (RZV) and zoster vaccine live (ZVL), with different formulations assessed. Detailed feasibility assessment indicated that a NMA was feasible for efficacy (incidence of HZ and postherpetic neuralgia [PHN]) and safety (serious adverse events [SAE] and reactogenicity [injection-site reactions, systemic reaction]) outcomes. Primary analyses included frequentist NMAs with fixed effects for efficacy outcomes, due to limited data availability, and both fixed and random effects for safety and reactogenicity outcomes. As age is a known effect modifier of vaccine efficacy (VE), VE analyses were stratified by age. Results: RZV demonstrated significantly higher HZ efficacy than ZVL in adults \u226560 years of age (YOA) (VE RZV = 0.92 (95% confidence interval [95%CI]: 0.88, 0.94), VE ZVL = 0.51 (95%CI: 0.44, 0.57)) and adults \u226570 YOA (VE RZV = 0.91 (95%CI: 0.87, 0.94), VE ZVL = 0.37 (95%CI: 0.25, 0.48)). Similarly, RZV demonstrated significantly higher PHN efficacy than ZVL in adults \u226560 YOA (VE RZV = 0.89 (95%CI: 0.70, 0.96), VE ZVL = 0.66 (95%CI: 0.48, 0.78)) and adults \u226570 YOA (VE RZV = 0.89 (95%CI: 0.69, 0.96), VE ZVL = 0.67 (95%CI: 0.44, 0.80)). RZV was associated with significantly more injection-site and systemic reactions compared to most formulations of ZVL and placebo, however definitions and data collection procedures differed across the included studies. There were no statistically significant differences found between RZV and any formulation of ZVL or placebo for SAEs. Conclusion: RZV is significantly more effective in reducing HZ and PHN incidence in adults \u226560 YOA, compared with ZVL. As anticipated with an adjuvanted vaccine, RZV results in more reactogenicity following immunization. No differences in SAEs were found between RZV and ZVL. ",
    "author_highlights": [
        {
            "endOffset": 29453,
            "sentence": "Two vaccines are licensed in the US and Canada to prevent shingles in \u226550-year-olds.",
            "startOffset": 29369
        },
        {
            "endOffset": 29538,
            "sentence": "We compare the efficacy, reactogenicity, and safety of these vaccines (ZVL and RZV).",
            "startOffset": 29454
        },
        {
            "endOffset": 29604,
            "sentence": "The short term reactogenicity of RZV was higher than that of ZVL.",
            "startOffset": 29539
        },
        {
            "endOffset": 29651,
            "sentence": "Both vaccines have comparable safety profiles.",
            "startOffset": 29605
        },
        {
            "endOffset": 29733,
            "sentence": "The vaccine efficacy (VE) of RZV was greater than the VE of ZVL in \u226560-year-olds.",
            "startOffset": 29652
        }
    ],
    "bib_entries": {
        "b0005": {
            "authors": [
                {
                    "first": "Guy",
                    "initial": "G.",
                    "last": "Boivin"
                },
                {
                    "first": "Roman",
                    "initial": "R.",
                    "last": "Jovey"
                },
                {
                    "first": "Catherine T.",
                    "initial": "C.T.",
                    "last": "Elliott"
                },
                {
                    "first": "David M.",
                    "initial": "D.M.",
                    "last": "Patrick"
                }
            ],
            "doi": "10.1155/2010/178036",
            "firstpage": "45",
            "issn": "17129532",
            "lastpage": "52",
            "pub_year": 2010,
            "title": "Management and prevention of herpes zoster: A Canadian perspective",
            "volume": "21"
        },
        "b0010": {
            "authors": [
                {
                    "first": "Niklaus H.",
                    "initial": "N.H.",
                    "last": "Mueller"
                },
                {
                    "first": "Donald H.",
                    "initial": "D.H.",
                    "last": "Gilden"
                },
                {
                    "first": "Randall J.",
                    "initial": "R.J.",
                    "last": "Cohrs"
                },
                {
                    "first": "Ravi",
                    "initial": "R.",
                    "last": "Mahalingam"
                },
                {
                    "first": "Maria A.",
                    "initial": "M.A.",
                    "last": "Nagel"
                }
            ],
            "doi": "10.1016/j.ncl.2008.03.011",
            "firstpage": "675",
            "issn": "07338619",
            "lastpage": "697",
            "pmid": "18657721",
            "pub_year": 2008,
            "title": "Varicella Zoster Virus Infection: Clinical Features, Molecular Pathogenesis of Disease, and Latency",
            "volume": "26"
        },
        "b0015": {
            "authors": [
                {
                    "first": "Robert W.",
                    "initial": "R.W.",
                    "last": "Johnson"
                },
                {
                    "first": "Didier",
                    "initial": "D.",
                    "last": "Bouhassira"
                },
                {
                    "first": "George",
                    "initial": "G.",
                    "last": "Kassianos"
                },
                {
                    "first": "Alain",
                    "initial": "A.",
                    "last": "Lepl\u00e8ge"
                },
                {
                    "first": "Kenneth E.",
                    "initial": "K.E.",
                    "last": "Schmader"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Weinke"
                }
            ],
            "doi": "10.1186/1741-7015-8-37",
            "issn": "17417015",
            "pmid": "20565946",
            "pub_year": 2010,
            "title": "The impact of herpes zoster and post-herpetic neuralgia on quality-of-life",
            "volume": "8"
        },
        "b0020": null,
        "b0025": {
            "authors": [
                {
                    "first": "M. N.",
                    "initial": "M.N.",
                    "last": "Oxman"
                },
                {
                    "first": "M. J.",
                    "initial": "M.J.",
                    "last": "Levin"
                },
                {
                    "first": "G. R.",
                    "initial": "G.R.",
                    "last": "Johnson"
                },
                {
                    "first": "K. E.",
                    "initial": "K.E.",
                    "last": "Schmader"
                },
                {
                    "first": "S. E.",
                    "initial": "S.E.",
                    "last": "Straus"
                },
                {
                    "first": "L. D.",
                    "initial": "L.D.",
                    "last": "Gelb"
                },
                {
                    "first": "R. D.",
                    "initial": "R.D.",
                    "last": "Arbeit"
                },
                {
                    "first": "M. S.",
                    "initial": "M.S.",
                    "last": "Simberkoff"
                },
                {
                    "first": "A. A.",
                    "initial": "A.A.",
                    "last": "Gershon"
                },
                {
                    "first": "L. E.",
                    "initial": "L.E.",
                    "last": "Davis"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Weinberg"
                },
                {
                    "first": "K. D.",
                    "initial": "K.D.",
                    "last": "Boardman"
                },
                {
                    "first": "H. M.",
                    "initial": "H.M.",
                    "last": "Williams"
                },
                {
                    "first": "J. Hongyuan",
                    "initial": "J.H.",
                    "last": "Zhang"
                },
                {
                    "first": "P. N.",
                    "initial": "P.N.",
                    "last": "Peduzzi"
                },
                {
                    "first": "C. E.",
                    "initial": "C.E.",
                    "last": "Beisel"
                },
                {
                    "first": "V. A.",
                    "initial": "V.A.",
                    "last": "Morrison"
                },
                {
                    "first": "J. C.",
                    "initial": "J.C.",
                    "last": "Guatelli"
                },
                {
                    "first": "P. A.",
                    "initial": "P.A.",
                    "last": "Brooks"
                },
                {
                    "first": "C. A.",
                    "initial": "C.A.",
                    "last": "Kauffman"
                },
                {
                    "first": "C. T.",
                    "initial": "C.T.",
                    "last": "Pachucki"
                },
                {
                    "first": "K. M.",
                    "initial": "K.M.",
                    "last": "Neuzil"
                },
                {
                    "first": "R. F.",
                    "initial": "R.F.",
                    "last": "Betts"
                },
                {
                    "first": "P. F.",
                    "initial": "P.F.",
                    "last": "Wright"
                },
                {
                    "first": "M. R.",
                    "initial": "M.R.",
                    "last": "Griffin"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Brunell"
                },
                {
                    "first": "N. E.",
                    "initial": "N.E.",
                    "last": "Soto"
                },
                {
                    "first": "A. R.",
                    "initial": "A.R.",
                    "last": "Marques"
                },
                {
                    "first": "S. K.",
                    "initial": "S.K.",
                    "last": "Keay"
                },
                {
                    "first": "R. P.",
                    "initial": "R.P.",
                    "last": "Goodman"
                },
                {
                    "first": "D. J.",
                    "initial": "D.J.",
                    "last": "Cotton"
                },
                {
                    "first": "J. W.",
                    "initial": "J.W.",
                    "last": "Gnann"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Loutit"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Holodniy"
                },
                {
                    "first": "W. A.",
                    "initial": "W.A.",
                    "last": "Keitel"
                },
                {
                    "first": "G. E.",
                    "initial": "G.E.",
                    "last": "Crawford"
                },
                {
                    "first": "S. S.",
                    "initial": "S.S.",
                    "last": "Yeh"
                },
                {
                    "first": "Z.",
                    "initial": "Z.",
                    "last": "Lobo"
                },
                {
                    "first": "J. F.",
                    "initial": "J.F.",
                    "last": "Toney"
                },
                {
                    "first": "R. N.",
                    "initial": "R.N.",
                    "last": "Greenberg"
                },
                {
                    "first": "P. M.",
                    "initial": "P.M.",
                    "last": "Keller"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Harbecke"
                },
                {
                    "first": "A. R.",
                    "initial": "A.R.",
                    "last": "Hayward"
                },
                {
                    "first": "M. R.",
                    "initial": "M.R.",
                    "last": "Irwin"
                },
                {
                    "first": "T. C.",
                    "initial": "T.C.",
                    "last": "Kyriakides"
                },
                {
                    "first": "C. Y.",
                    "initial": "C.Y.",
                    "last": "Chan"
                },
                {
                    "first": "I. S.F.",
                    "initial": "I.S.F.",
                    "last": "Chan"
                },
                {
                    "first": "W. W.B.",
                    "initial": "W.W.B.",
                    "last": "Wang"
                },
                {
                    "first": "P. W.",
                    "initial": "P.W.",
                    "last": "Annunziato"
                },
                {
                    "first": "J. L.",
                    "initial": "J.L.",
                    "last": "Silber"
                }
            ],
            "doi": "10.1056/NEJMoa051016",
            "firstpage": "2271",
            "issn": "00284793",
            "lastpage": "2365",
            "pmid": "15930418",
            "pub_year": 2005,
            "title": "A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults",
            "volume": "352"
        },
        "b0030": {
            "authors": [
                {
                    "first": "Kenneth E.",
                    "initial": "K.E.",
                    "last": "Schmader"
                },
                {
                    "first": "Myron J.",
                    "initial": "M.J.",
                    "last": "Levin"
                },
                {
                    "first": "John W.",
                    "initial": "J.W.",
                    "last": "Gnann"
                },
                {
                    "first": "Shelly A.",
                    "initial": "S.A.",
                    "last": "McNeil"
                },
                {
                    "first": "Timo",
                    "initial": "T.",
                    "last": "Vesikari"
                },
                {
                    "first": "Robert F.",
                    "initial": "R.F.",
                    "last": "Betts"
                },
                {
                    "first": "Susan",
                    "initial": "S.",
                    "last": "Keay"
                },
                {
                    "first": "Jon E.",
                    "initial": "J.E.",
                    "last": "Stek"
                },
                {
                    "first": "Nickoya D.",
                    "initial": "N.D.",
                    "last": "Bundick"
                },
                {
                    "first": "Shu Chih",
                    "initial": "S.C.",
                    "last": "Su"
                },
                {
                    "first": "Yanli",
                    "initial": "Y.",
                    "last": "Zhao"
                },
                {
                    "first": "Xiaoming",
                    "initial": "X.",
                    "last": "Li"
                },
                {
                    "first": "Ivan S.F.",
                    "initial": "I.S.F.",
                    "last": "Chan"
                },
                {
                    "first": "Paula W.",
                    "initial": "P.W.",
                    "last": "Annunziato"
                },
                {
                    "first": "Janie",
                    "initial": "J.",
                    "last": "Parrino"
                }
            ],
            "doi": "10.1093/cid/cir970",
            "firstpage": "922",
            "issn": "10584838",
            "lastpage": "928",
            "pmid": "22291101",
            "pub_year": 2012,
            "title": "Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years",
            "volume": "54"
        },
        "b0035": null,
        "b0040": null,
        "b0045": {
            "authors": [
                {
                    "first": "Himal",
                    "initial": "H.",
                    "last": "Lal"
                },
                {
                    "first": "Anthony L.",
                    "initial": "A.L.",
                    "last": "Cunningham"
                },
                {
                    "first": "Olivier",
                    "initial": "O.",
                    "last": "Godeaux"
                },
                {
                    "first": "Roman",
                    "initial": "R.",
                    "last": "Chlibek"
                },
                {
                    "first": "Javier",
                    "initial": "J.",
                    "last": "Diez-Domingo"
                },
                {
                    "first": "Shinn Jang",
                    "initial": "S.J.",
                    "last": "Hwang"
                },
                {
                    "first": "Myron J.",
                    "initial": "M.J.",
                    "last": "Levin"
                },
                {
                    "first": "Janet E.",
                    "initial": "J.E.",
                    "last": "McElhaney"
                },
                {
                    "first": "Airi",
                    "initial": "A.",
                    "last": "Poder"
                },
                {
                    "first": "Joan",
                    "initial": "J.",
                    "last": "Puig-Barber\u00e0"
                },
                {
                    "first": "Timo",
                    "initial": "T.",
                    "last": "Vesikari"
                },
                {
                    "first": "Daisuke",
                    "initial": "D.",
                    "last": "Watanabe"
                },
                {
                    "first": "Lily",
                    "initial": "L.",
                    "last": "Weckx"
                },
                {
                    "first": "Toufik",
                    "initial": "T.",
                    "last": "Zahaf"
                },
                {
                    "first": "Thomas C.",
                    "initial": "T.C.",
                    "last": "Heineman"
                },
                {
                    "first": null,
                    "initial": null,
                    "last": null
                }
            ],
            "doi": "10.1056/NEJMoa1501184",
            "firstpage": "2087",
            "issn": "00284793",
            "lastpage": "2096",
            "pmid": "25916341",
            "pub_year": 2015,
            "title": "Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults",
            "volume": "372"
        },
        "b0050": {
            "authors": [
                {
                    "first": "A. L.",
                    "initial": "A.L.",
                    "last": "Cunningham"
                },
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "Lal"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Kovac"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Chlibek"
                },
                {
                    "first": "S. J.",
                    "initial": "S.J.",
                    "last": "Hwang"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "D\u00edez-Domingo"
                },
                {
                    "first": "O.",
                    "initial": "O.",
                    "last": "Godeaux"
                },
                {
                    "first": "M. J.",
                    "initial": "M.J.",
                    "last": "Levin"
                },
                {
                    "first": "J. E.",
                    "initial": "J.E.",
                    "last": "McElhaney"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Puig-Barber\u00e0"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Vanden Abeele"
                },
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Vesikari"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Watanabe"
                },
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Zahaf"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Ahonen"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Athan"
                },
                {
                    "first": "J. F.",
                    "initial": "J.F.",
                    "last": "Barba-Gomez"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Campora"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "De Looze"
                },
                {
                    "first": "H. J.",
                    "initial": "H.J.",
                    "last": "Downey"
                },
                {
                    "first": "W.",
                    "initial": "W.",
                    "last": "Ghesquiere"
                },
                {
                    "first": "I.",
                    "initial": "I.",
                    "last": "Gorfinkel"
                },
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Korhonen"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Leung"
                },
                {
                    "first": "S. A.",
                    "initial": "S.A.",
                    "last": "McNeil"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Oostvogels"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Rombo"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Smetana"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Weckx"
                },
                {
                    "first": "W.",
                    "initial": "W.",
                    "last": "Yeo"
                },
                {
                    "first": "T. C.",
                    "initial": "T.C.",
                    "last": "Heineman"
                }
            ],
            "doi": "10.1056/NEJMoa1603800",
            "firstpage": "1019",
            "issn": "00284793",
            "lastpage": "1032",
            "pmid": "27626517",
            "pub_year": 2016,
            "title": "Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older",
            "volume": "375"
        },
        "b0055": {
            "authors": [
                {
                    "first": "Anna M.Z.",
                    "initial": "A.M.Z.",
                    "last": "Gagliardi"
                },
                {
                    "first": "Brenda Nazar\u00e9",
                    "initial": "B.N.",
                    "last": "Gomes Silva"
                },
                {
                    "first": "Maria R.",
                    "initial": "M.R.",
                    "last": "Torloni"
                },
                {
                    "first": "Bernardo G.O.",
                    "initial": "B.G.O.",
                    "last": "Soares"
                }
            ],
            "firstpage": "CD008858",
            "issn": "1469493X",
            "pmid": "23076951",
            "pub_year": 2012,
            "title": "Vaccines for preventing herpes zoster in older adults.",
            "volume": "10"
        },
        "b0060": null,
        "b0065": {
            "authors": [
                {
                    "first": "Jeroen P.",
                    "initial": "J.P.",
                    "last": "Jansen"
                },
                {
                    "first": "Huseyin",
                    "initial": "H.",
                    "last": "Naci"
                }
            ],
            "doi": "10.1186/1741-7015-11-159",
            "issn": "17417015",
            "pmid": "23826681",
            "pub_year": 2013,
            "title": "Is network meta-analysis as valid as standard pairwise meta-analysis? It all depends on the distribution of effect modifiers",
            "volume": "11"
        },
        "b0070": {
            "authors": [
                {
                    "first": "Andrea C.",
                    "initial": "A.C.",
                    "last": "Tricco"
                },
                {
                    "first": "Wasifa",
                    "initial": "W.",
                    "last": "Zarin"
                },
                {
                    "first": "Roberta",
                    "initial": "R.",
                    "last": "Cardoso"
                },
                {
                    "first": "Areti Angeliki",
                    "initial": "A.A.",
                    "last": "Veroniki"
                },
                {
                    "first": "Paul A.",
                    "initial": "P.A.",
                    "last": "Khan"
                },
                {
                    "first": "Vera",
                    "initial": "V.",
                    "last": "Nincic"
                },
                {
                    "first": "Marco",
                    "initial": "M.",
                    "last": "Ghassemi"
                },
                {
                    "first": "Rachel",
                    "initial": "R.",
                    "last": "Warren"
                },
                {
                    "first": "Jane P.",
                    "initial": "J.P.",
                    "last": "Sharpe"
                },
                {
                    "first": "Andrea V.",
                    "initial": "A.V.",
                    "last": "Page"
                },
                {
                    "first": "Sharon E.",
                    "initial": "S.E.",
                    "last": "Straus"
                }
            ],
            "doi": "10.1136/bmj.k4029",
            "issn": "09598146",
            "pmid": "30361202",
            "pub_year": 2018,
            "title": "Efficacy, effectiveness, and safety of herpes zoster vaccines in adults aged 50 and older: Systematic review and network meta-analysis",
            "volume": "363"
        },
        "b0075": null,
        "b0080": null,
        "b0085": {
            "authors": [
                {
                    "first": "Shannon",
                    "initial": "S.",
                    "last": "Cope"
                },
                {
                    "first": "Jie",
                    "initial": "J.",
                    "last": "Zhang"
                },
                {
                    "first": "Stephen",
                    "initial": "S.",
                    "last": "Saletan"
                },
                {
                    "first": "Brielan",
                    "initial": "B.",
                    "last": "Smiechowski"
                },
                {
                    "first": "Jeroen P.",
                    "initial": "J.P.",
                    "last": "Jansen"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Schmid"
                }
            ],
            "doi": "10.1186/1741-7015-12-93",
            "issn": "17417015",
            "pmid": "24898705",
            "pub_year": 2014,
            "title": "A process for assessing the feasibility of a network meta-analysis: A case study of everolimus in combination with hormonal therapy versus chemotherapy for advanced breast cancer",
            "volume": "12"
        },
        "b0090": null,
        "b0095": {
            "authors": [
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Hata"
                },
                {
                    "first": "F.",
                    "initial": "F.",
                    "last": "Inoue"
                },
                {
                    "first": "Y.",
                    "initial": "Y.",
                    "last": "Hamamoto"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Yamasaki"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Fujikawa"
                },
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "Kawahara"
                },
                {
                    "first": "Y.",
                    "initial": "Y.",
                    "last": "Kawasaki"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Honjo"
                },
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "Koshiyama"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Moriishi"
                },
                {
                    "first": "Y.",
                    "initial": "Y.",
                    "last": "Mori"
                },
                {
                    "first": "T.",
                    "initial": "T.",
                    "last": "Ohkubo"
                }
            ],
            "doi": "10.1111/dme.13038",
            "firstpage": "1094",
            "issn": "07423071",
            "lastpage": "1101",
            "pmid": "26605507",
            "pub_year": 2016,
            "title": "Efficacy and safety of live varicella zoster vaccine in diabetes: a randomized, double-blind, placebo-controlled trial",
            "volume": "33"
        },
        "b0100": {
            "authors": [
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Vink"
                },
                {
                    "first": "Masanari",
                    "initial": "M.",
                    "last": "Shiramoto"
                },
                {
                    "first": "Masayuki",
                    "initial": "M.",
                    "last": "Ogawa"
                },
                {
                    "first": "Masahiro",
                    "initial": "M.",
                    "last": "Eda"
                },
                {
                    "first": "Martine",
                    "initial": "M.",
                    "last": "Douha"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Heineman"
                },
                {
                    "first": "Himal",
                    "initial": "H.",
                    "last": "Lal"
                }
            ],
            "doi": "10.1080/21645515.2016.1232787",
            "firstpage": "574",
            "issn": "21645515",
            "lastpage": "578",
            "pmid": "27936344",
            "pub_year": 2017,
            "title": "Safety and immunogenicity of a Herpes Zoster subunit vaccine in Japanese population aged \u226550\u00a0years when administered subcutaneously vs. intramuscularly",
            "volume": "13"
        },
        "b0105": null,
        "b0110": null,
        "b0115": null,
        "b0120": {
            "authors": [
                {
                    "first": "Chan R.",
                    "initial": "C.R.",
                    "last": "Beals"
                },
                {
                    "first": "Radha A.",
                    "initial": "R.A.",
                    "last": "Railkar"
                },
                {
                    "first": "Andrea K.",
                    "initial": "A.K.",
                    "last": "Schaeffer"
                },
                {
                    "first": "Yotam",
                    "initial": "Y.",
                    "last": "Levin"
                },
                {
                    "first": "Efrat",
                    "initial": "E.",
                    "last": "Kochba"
                },
                {
                    "first": "Brian K.",
                    "initial": "B.K.",
                    "last": "Meyer"
                },
                {
                    "first": "Robert K.",
                    "initial": "R.K.",
                    "last": "Evans"
                },
                {
                    "first": "Eric A.",
                    "initial": "E.A.",
                    "last": "Sheldon"
                },
                {
                    "first": "Kenneth",
                    "initial": "K.",
                    "last": "Lasseter"
                },
                {
                    "first": "Nancy",
                    "initial": "N.",
                    "last": "Lang"
                },
                {
                    "first": "Adriana",
                    "initial": "A.",
                    "last": "Weinberg"
                },
                {
                    "first": "Jennifer",
                    "initial": "J.",
                    "last": "Canniff"
                },
                {
                    "first": "Myron J.",
                    "initial": "M.J.",
                    "last": "Levin"
                }
            ],
            "doi": "10.1016/S1473-3099(16)00133-X",
            "firstpage": "915",
            "issn": "14733099",
            "lastpage": "922",
            "pmid": "27061887",
            "pub_year": 2016,
            "title": "Immune response and reactogenicity of intradermal administration versus subcutaneous administration of varicella-zoster virus vaccine: an exploratory, randomised, partly blinded trial",
            "volume": "16"
        },
        "b0125": {
            "authors": [
                {
                    "first": "Rosemarie",
                    "initial": "R.",
                    "last": "Berger"
                },
                {
                    "first": "Emanuelle",
                    "initial": "E.",
                    "last": "Trannoy"
                },
                {
                    "first": "Georges",
                    "initial": "G.",
                    "last": "Holl\u00e4nder"
                },
                {
                    "first": "Fabrice",
                    "initial": "F.",
                    "last": "Bailleux"
                },
                {
                    "first": "Christophe",
                    "initial": "C.",
                    "last": "Rudin"
                },
                {
                    "first": "Herv\u00e9",
                    "initial": "H.",
                    "last": "Creusvaux"
                }
            ],
            "firstpage": "S99",
            "issn": "00221899",
            "lastpage": "S103",
            "pmid": "9852985",
            "pub_year": 1998,
            "title": "A dose-response study of a live attenuated varicella-zoster virus (oka strain) vaccine administered to adults 55 years of age and older",
            "volume": "178"
        },
        "b0130": {
            "authors": [
                {
                    "first": "Roman",
                    "initial": "R.",
                    "last": "Chlibek"
                },
                {
                    "first": "Jos\u00e9 M.",
                    "initial": "J.M.",
                    "last": "Bayas"
                },
                {
                    "first": "Harry",
                    "initial": "H.",
                    "last": "Collins"
                },
                {
                    "first": "Maria Luisa Rodriguez",
                    "initial": "M.L.R.",
                    "last": "De La Pinta"
                },
                {
                    "first": "Edouard",
                    "initial": "E.",
                    "last": "Ledent"
                },
                {
                    "first": "Johann F.",
                    "initial": "J.F.",
                    "last": "Mols"
                },
                {
                    "first": "Thomas C.",
                    "initial": "T.C.",
                    "last": "Heineman"
                }
            ],
            "doi": "10.1093/infdis/jit365",
            "firstpage": "1953",
            "issn": "00221899",
            "lastpage": "1961",
            "pmid": "23904292",
            "pub_year": 2013,
            "title": "Safety and immunogenicity of an ASO1 -adjuvanted varicella-zoster virus subunit candidate vaccine against herpes zoster in adults \u226550 years of age",
            "volume": "208"
        },
        "b0135": null,
        "b0140": {
            "authors": [
                {
                    "first": "Javier",
                    "initial": "J.",
                    "last": "Diez-Domingo"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Weinke"
                },
                {
                    "first": "Juan",
                    "initial": "J.",
                    "last": "Garcia de Lomas"
                },
                {
                    "first": "Claudius U.",
                    "initial": "C.U.",
                    "last": "Meyer"
                },
                {
                    "first": "Isabelle",
                    "initial": "I.",
                    "last": "Bertrand"
                },
                {
                    "first": "C\u00e9cile",
                    "initial": "C.",
                    "last": "Eymin"
                },
                {
                    "first": "St\u00e9phane",
                    "initial": "S.",
                    "last": "Thomas"
                },
                {
                    "first": "Christine",
                    "initial": "C.",
                    "last": "Sadorge"
                }
            ],
            "doi": "10.1016/j.vaccine.2014.12.024",
            "firstpage": "789",
            "issn": "0264410X",
            "lastpage": "795",
            "pmid": "25555381",
            "pub_year": 2015,
            "title": "Comparison of intramuscular and subcutaneous administration of a herpes zoster live-attenuated vaccine in adults aged \u226550 years: A randomised non-inferiority clinical trial",
            "volume": "33"
        },
        "b0145": {
            "authors": [
                {
                    "first": "Larry I.",
                    "initial": "L.I.",
                    "last": "Gilderman"
                },
                {
                    "first": "James F.",
                    "initial": "J.F.",
                    "last": "Lawless"
                },
                {
                    "first": "Thomas M.",
                    "initial": "T.M.",
                    "last": "Nolen"
                },
                {
                    "first": "Tina",
                    "initial": "T.",
                    "last": "Sterling"
                },
                {
                    "first": "Ruth Z.",
                    "initial": "R.Z.",
                    "last": "Rutledge"
                },
                {
                    "first": "Doreen A.",
                    "initial": "D.A.",
                    "last": "Fernsler"
                },
                {
                    "first": "Neal",
                    "initial": "N.",
                    "last": "Azrolan"
                },
                {
                    "first": "Santosh C.",
                    "initial": "S.C.",
                    "last": "Sutradhar"
                },
                {
                    "first": "William W.",
                    "initial": "W.W.",
                    "last": "Wang"
                },
                {
                    "first": "Ivan S.F.",
                    "initial": "I.S.F.",
                    "last": "Chan"
                },
                {
                    "first": "Katia",
                    "initial": "K.",
                    "last": "Schlienger"
                },
                {
                    "first": "Florian",
                    "initial": "F.",
                    "last": "Sch\u00f6del"
                },
                {
                    "first": "Jeffrey L.",
                    "initial": "J.L.",
                    "last": "Silber"
                }
            ],
            "doi": "10.1128/CVI.00310-07",
            "firstpage": "314",
            "issn": "15566811",
            "lastpage": "319",
            "pmid": "18077611",
            "pub_year": 2008,
            "title": "A double-blind, randomized, controlled, multicenter safety and immunogenicity study of a refrigerator-stable formulation of Zostavax",
            "volume": "15"
        },
        "b0150": {
            "authors": [
                {
                    "first": "Boris",
                    "initial": "B.",
                    "last": "Kerzner"
                },
                {
                    "first": "Alexander V.",
                    "initial": "A.V.",
                    "last": "Murray"
                },
                {
                    "first": "Eric",
                    "initial": "E.",
                    "last": "Cheng"
                },
                {
                    "first": "Rudy",
                    "initial": "R.",
                    "last": "Ifle"
                },
                {
                    "first": "Peter R.",
                    "initial": "P.R.",
                    "last": "Harvey"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Tomlinson"
                },
                {
                    "first": "Julie L.",
                    "initial": "J.L.",
                    "last": "Barben"
                },
                {
                    "first": "Kimberly",
                    "initial": "K.",
                    "last": "Rarrick"
                },
                {
                    "first": "Jon E.",
                    "initial": "J.E.",
                    "last": "Stek"
                },
                {
                    "first": "Mi Ok",
                    "initial": "M.O.",
                    "last": "Chung"
                },
                {
                    "first": "Florian P.",
                    "initial": "F.P.",
                    "last": "Sch\u00f6del"
                },
                {
                    "first": "William W.B.",
                    "initial": "W.W.B.",
                    "last": "Wang"
                },
                {
                    "first": "Jin",
                    "initial": "J.",
                    "last": "Xu"
                },
                {
                    "first": "Ivan S.F.",
                    "initial": "I.S.F.",
                    "last": "Chan"
                },
                {
                    "first": "Jeffrey L.",
                    "initial": "J.L.",
                    "last": "Silber"
                },
                {
                    "first": "Katia",
                    "initial": "K.",
                    "last": "Schlienger"
                }
            ],
            "doi": "10.1111/j.1532-5415.2007.01397.x",
            "firstpage": "1499",
            "issn": "00028614",
            "lastpage": "1507",
            "pmid": "17908055",
            "pub_year": 2007,
            "title": "Safety and immunogenicity profile of the concomitant administration of ZOSTAVAX and inactivated influenza vaccine in adults aged 50 and older",
            "volume": "55"
        },
        "b0155": {
            "authors": [
                {
                    "first": "C. Raina",
                    "initial": "C.R.",
                    "last": "MacIntyre"
                },
                {
                    "first": "Tony",
                    "initial": "T.",
                    "last": "Egerton"
                },
                {
                    "first": "Malcolm",
                    "initial": "M.",
                    "last": "McCaughey"
                },
                {
                    "first": "Janie",
                    "initial": "J.",
                    "last": "Parrino"
                },
                {
                    "first": "Bernadette V.",
                    "initial": "B.V.",
                    "last": "Campbell"
                },
                {
                    "first": "Shu Chih",
                    "initial": "S.C.",
                    "last": "Su"
                },
                {
                    "first": "Marco F.",
                    "initial": "M.F.",
                    "last": "Pagnoni"
                },
                {
                    "first": "Jon E.",
                    "initial": "J.E.",
                    "last": "Stek"
                },
                {
                    "first": "Jin",
                    "initial": "J.",
                    "last": "Xu"
                },
                {
                    "first": "Paula W.",
                    "initial": "P.W.",
                    "last": "Annunziato"
                },
                {
                    "first": "Ivan S.F.",
                    "initial": "I.S.F.",
                    "last": "Chan"
                },
                {
                    "first": "Jeffrey L.",
                    "initial": "J.L.",
                    "last": "Silber"
                }
            ],
            "doi": "10.4161/hv.6.11.12852",
            "firstpage": "894",
            "issn": "15548600",
            "lastpage": "902",
            "pmid": "20980796",
            "pub_year": 2010,
            "title": "Concomitant administration of zoster and pneumococcal vaccines in adults \u226560 years old",
            "volume": "6"
        },
        "b0160": null,
        "b0165": {
            "authors": [
                {
                    "first": "Alexander V.",
                    "initial": "A.V.",
                    "last": "Murray"
                },
                {
                    "first": "Keith S.",
                    "initial": "K.S.",
                    "last": "Reisinger"
                },
                {
                    "first": "Boris",
                    "initial": "B.",
                    "last": "Kerzner"
                },
                {
                    "first": "Jon E.",
                    "initial": "J.E.",
                    "last": "Stek"
                },
                {
                    "first": "Timothy A.",
                    "initial": "T.A.",
                    "last": "Sausser"
                },
                {
                    "first": "Jin",
                    "initial": "J.",
                    "last": "Xu"
                },
                {
                    "first": "William W.",
                    "initial": "W.W.",
                    "last": "Wang"
                },
                {
                    "first": "Ivan S.F.",
                    "initial": "I.S.F.",
                    "last": "Chan"
                },
                {
                    "first": "Paula W.",
                    "initial": "P.W.",
                    "last": "Annunziato"
                },
                {
                    "first": "Janie",
                    "initial": "J.",
                    "last": "Parrino"
                }
            ],
            "doi": "10.4161/hv.7.11.17982",
            "firstpage": "1130",
            "issn": "15548600",
            "lastpage": "1136",
            "pub_year": 2011,
            "title": "Safety and tolerability of zoster vaccine in adults \u226560 years old",
            "volume": "7"
        },
        "b0170": {
            "authors": [
                {
                    "first": "Michael N.",
                    "initial": "M.N.",
                    "last": "Oxman"
                },
                {
                    "first": "Myron J.",
                    "initial": "M.J.",
                    "last": "Levin"
                },
                {
                    "first": "Robert D.",
                    "initial": "R.D.",
                    "last": "Arbeit"
                },
                {
                    "first": "Patricia",
                    "initial": "P.",
                    "last": "Barry"
                },
                {
                    "first": "Chris",
                    "initial": "C.",
                    "last": "Beisel"
                },
                {
                    "first": "Kathy D.",
                    "initial": "K.D.",
                    "last": "Boardman"
                },
                {
                    "first": "Cindy L.",
                    "initial": "C.L.",
                    "last": "Colling"
                },
                {
                    "first": "Larry E.",
                    "initial": "L.E.",
                    "last": "Davis"
                },
                {
                    "first": "Lawrence D.",
                    "initial": "L.D.",
                    "last": "Gelb"
                },
                {
                    "first": "Anne A.",
                    "initial": "A.A.",
                    "last": "Gershon"
                },
                {
                    "first": "Anthony R.",
                    "initial": "A.R.",
                    "last": "Hayward"
                },
                {
                    "first": "Michael R.",
                    "initial": "M.R.",
                    "last": "Irwin"
                },
                {
                    "first": "Gary R.",
                    "initial": "G.R.",
                    "last": "Johnson"
                },
                {
                    "first": "Peter N.",
                    "initial": "P.N.",
                    "last": "Peduzzi"
                },
                {
                    "first": "Kenneth E.",
                    "initial": "K.E.",
                    "last": "Schmader"
                },
                {
                    "first": "Michael S.",
                    "initial": "M.S.",
                    "last": "Simberkoff"
                },
                {
                    "first": "Stephen E.",
                    "initial": "S.E.",
                    "last": "Straus"
                },
                {
                    "first": "Adriana",
                    "initial": "A.",
                    "last": "Weinberg"
                },
                {
                    "first": "Heather M.",
                    "initial": "H.M.",
                    "last": "Williams"
                },
                {
                    "first": "Paula",
                    "initial": "P.",
                    "last": "Annunziato"
                },
                {
                    "first": "Christina Y.",
                    "initial": "C.Y.",
                    "last": "Chan"
                },
                {
                    "first": "Ivan S.F.",
                    "initial": "I.S.F.",
                    "last": "Chan"
                },
                {
                    "first": "Jeffrey L.",
                    "initial": "J.L.",
                    "last": "Silber"
                },
                {
                    "first": "L. E.",
                    "initial": "L.E.",
                    "last": "Davis"
                },
                {
                    "first": "C. A.",
                    "initial": "C.A.",
                    "last": "Kauffman"
                },
                {
                    "first": "S. K.",
                    "initial": "S.K.",
                    "last": "Keay"
                },
                {
                    "first": "A. R.",
                    "initial": "A.R.",
                    "last": "Marques"
                },
                {
                    "first": "N. E.",
                    "initial": "N.E.",
                    "last": "Soto"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Brunell"
                },
                {
                    "first": "J. W.",
                    "initial": "J.W.",
                    "last": "Gnann"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Serrao"
                },
                {
                    "first": "D. J.",
                    "initial": "D.J.",
                    "last": "Cotton"
                },
                {
                    "first": "R. P.",
                    "initial": "R.P.",
                    "last": "Goodman"
                },
                {
                    "first": "R. D.",
                    "initial": "R.D.",
                    "last": "Arbeit"
                },
                {
                    "first": "C. T.",
                    "initial": "C.T.",
                    "last": "Pachucki"
                },
                {
                    "first": "K. E.",
                    "initial": "K.E.",
                    "last": "Schmader"
                },
                {
                    "first": "W. A.",
                    "initial": "W.A.",
                    "last": "Keitel"
                },
                {
                    "first": "R. N.",
                    "initial": "R.N.",
                    "last": "Greenberg"
                },
                {
                    "first": "V. A.",
                    "initial": "V.A.",
                    "last": "Morrison"
                },
                {
                    "first": "P. F.",
                    "initial": "P.F.",
                    "last": "Wright"
                },
                {
                    "first": "M. R.",
                    "initial": "M.R.",
                    "last": "Griffin"
                },
                {
                    "first": "M. S.",
                    "initial": "M.S.",
                    "last": "Simberkoff"
                },
                {
                    "first": "S. S.",
                    "initial": "S.S.",
                    "last": "Yeh"
                },
                {
                    "first": "Z.",
                    "initial": "Z.",
                    "last": "Lobo"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Holodniy"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Loutit"
                },
                {
                    "first": "R. F.",
                    "initial": "R.F.",
                    "last": "Betts"
                },
                {
                    "first": "L. D.",
                    "initial": "L.D.",
                    "last": "Gelb"
                },
                {
                    "first": "G. E.",
                    "initial": "G.E.",
                    "last": "Crawford"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Guatelli"
                },
                {
                    "first": "P. A.",
                    "initial": "P.A.",
                    "last": "Brooks"
                },
                {
                    "first": "K. M.",
                    "initial": "K.M.",
                    "last": "Neuzil"
                },
                {
                    "first": "J. F.",
                    "initial": "J.F.",
                    "last": "Toney"
                }
            ],
            "doi": "10.1086/522159",
            "firstpage": "S228",
            "issn": "00221899",
            "lastpage": "S236",
            "pmid": "18419402",
            "pub_year": 2008,
            "title": "Vaccination against herpes zoster and postherpetic neuralgia",
            "volume": "197"
        },
        "b0175": null,
        "b0180": {
            "authors": [
                {
                    "first": "Amy F.",
                    "initial": "A.F.",
                    "last": "Russell"
                },
                {
                    "first": "Janie",
                    "initial": "J.",
                    "last": "Parrino"
                },
                {
                    "first": "Chester L.",
                    "initial": "C.L.",
                    "last": "Fisher"
                },
                {
                    "first": "Wolfgang",
                    "initial": "W.",
                    "last": "Spieler"
                },
                {
                    "first": "Jon E.",
                    "initial": "J.E.",
                    "last": "Stek"
                },
                {
                    "first": "Kathleen E.",
                    "initial": "K.E.",
                    "last": "Coll"
                },
                {
                    "first": "Shu Chih",
                    "initial": "S.C.",
                    "last": "Su"
                },
                {
                    "first": "Jin",
                    "initial": "J.",
                    "last": "Xu"
                },
                {
                    "first": "Xiaoming",
                    "initial": "X.",
                    "last": "Li"
                },
                {
                    "first": "Katia",
                    "initial": "K.",
                    "last": "Schlienger"
                },
                {
                    "first": "Jeffrey L.",
                    "initial": "J.L.",
                    "last": "Silber"
                }
            ],
            "doi": "10.1016/j.vaccine.2015.04.090",
            "firstpage": "3129",
            "issn": "0264410X",
            "lastpage": "3134",
            "pmid": "25964168",
            "pub_year": 2015,
            "title": "Safety, tolerability, and immunogenicity of zoster vaccine in subjects on chronic/maintenance corticosteroids",
            "volume": "33"
        },
        "b0185": {
            "authors": [
                {
                    "first": "K. E.",
                    "initial": "K.E.",
                    "last": "Schmader"
                },
                {
                    "first": "M. N.",
                    "initial": "M.N.",
                    "last": "Oxman"
                },
                {
                    "first": "M. J.",
                    "initial": "M.J.",
                    "last": "Levin"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "Johnson"
                },
                {
                    "first": "J. H.",
                    "initial": "J.H.",
                    "last": "Zhang"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Betts"
                },
                {
                    "first": "V. A.",
                    "initial": "V.A.",
                    "last": "Morrison"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "Gelb"
                },
                {
                    "first": "J. C.",
                    "initial": "J.C.",
                    "last": "Guatelli"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Harbecke"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Pachucki"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Keay"
                },
                {
                    "first": "B.",
                    "initial": "B.",
                    "last": "Menzies"
                },
                {
                    "first": "M. R.",
                    "initial": "M.R.",
                    "last": "Griffin"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Kauffman"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Marques"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Toney"
                },
                {
                    "first": "P. M.",
                    "initial": "P.M.",
                    "last": "Keller"
                },
                {
                    "first": "X.",
                    "initial": "X.",
                    "last": "Li"
                },
                {
                    "first": "I. S.F.",
                    "initial": "I.S.F.",
                    "last": "Chan"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Annunziato"
                }
            ],
            "doi": "10.1093/cid/cis638",
            "firstpage": "1320",
            "issn": "10584838",
            "lastpage": "1328",
            "pmid": "22828595",
            "pub_year": 2012,
            "title": "Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy",
            "volume": "55"
        },
        "b0190": null,
        "b0195": {
            "authors": [
                {
                    "first": "Michael S.",
                    "initial": "M.S.",
                    "last": "Simberkoff"
                },
                {
                    "first": "Robert D.",
                    "initial": "R.D.",
                    "last": "Arbeit"
                },
                {
                    "first": "Gary R.",
                    "initial": "G.R.",
                    "last": "Johnson"
                },
                {
                    "first": "Michael N.",
                    "initial": "M.N.",
                    "last": "Oxman"
                },
                {
                    "first": "Kathy D.",
                    "initial": "K.D.",
                    "last": "Boardman"
                },
                {
                    "first": "Heather M.",
                    "initial": "H.M.",
                    "last": "Williams"
                },
                {
                    "first": "Myron J.",
                    "initial": "M.J.",
                    "last": "Levin"
                },
                {
                    "first": "Kenneth E.",
                    "initial": "K.E.",
                    "last": "Schmader"
                },
                {
                    "first": "Lawrence D.",
                    "initial": "L.D.",
                    "last": "Gelb"
                },
                {
                    "first": "Susan",
                    "initial": "S.",
                    "last": "Keay"
                },
                {
                    "first": "Kathleen",
                    "initial": "K.",
                    "last": "Neuzil"
                },
                {
                    "first": "Richard N.",
                    "initial": "R.N.",
                    "last": "Greenberg"
                },
                {
                    "first": "Marie R.",
                    "initial": "M.R.",
                    "last": "Griffin"
                },
                {
                    "first": "Larry E.",
                    "initial": "L.E.",
                    "last": "Davis"
                },
                {
                    "first": "Vicki A.",
                    "initial": "V.A.",
                    "last": "Morrison"
                },
                {
                    "first": "Paula W.",
                    "initial": "P.W.",
                    "last": "Annunziato"
                }
            ],
            "doi": "10.7326/0003-4819-152-9-201005040-00004",
            "firstpage": "545",
            "issn": "00034819",
            "lastpage": "554",
            "pmid": "20439572",
            "pub_year": 2010,
            "title": "Safety of herpes zoster vaccine in the Shingles prevention study: A randomized trial",
            "volume": "152"
        },
        "b0200": {
            "authors": [
                {
                    "first": "Stephen K.",
                    "initial": "S.K.",
                    "last": "Tyring"
                },
                {
                    "first": "Francisco",
                    "initial": "F.",
                    "last": "Diaz-Mitoma"
                },
                {
                    "first": "Larry G.",
                    "initial": "L.G.",
                    "last": "Padget"
                },
                {
                    "first": "Margarita",
                    "initial": "M.",
                    "last": "Nunez"
                },
                {
                    "first": "Gregory",
                    "initial": "G.",
                    "last": "Poland"
                },
                {
                    "first": "William M.",
                    "initial": "W.M.",
                    "last": "Cassidy"
                },
                {
                    "first": "Nickoya D.",
                    "initial": "N.D.",
                    "last": "Bundick"
                },
                {
                    "first": "Jianjun",
                    "initial": "J.",
                    "last": "Li"
                },
                {
                    "first": "Ivan S.F.",
                    "initial": "I.S.F.",
                    "last": "Chan"
                },
                {
                    "first": "Jon E.",
                    "initial": "J.E.",
                    "last": "Stek"
                },
                {
                    "first": "Paula W.",
                    "initial": "P.W.",
                    "last": "Annunziato"
                }
            ],
            "doi": "10.1016/j.vaccine.2006.10.027",
            "firstpage": "1877",
            "issn": "0264410X",
            "lastpage": "1883",
            "pmid": "17227688",
            "pub_year": 2007,
            "title": "Safety and tolerability of a high-potency zoster vaccine in adults \u226550 years of age",
            "volume": "25"
        },
        "b0205": {
            "authors": [
                {
                    "first": "Joost N.",
                    "initial": "J.N.",
                    "last": "Vermeulen"
                },
                {
                    "first": "Joep M.A.",
                    "initial": "J.M.A.",
                    "last": "Lange"
                },
                {
                    "first": "Stephen K.",
                    "initial": "S.K.",
                    "last": "Tyring"
                },
                {
                    "first": "Patrick H.",
                    "initial": "P.H.",
                    "last": "Peters"
                },
                {
                    "first": "Margaret",
                    "initial": "M.",
                    "last": "Nunez"
                },
                {
                    "first": "Gregory",
                    "initial": "G.",
                    "last": "Poland"
                },
                {
                    "first": "Myron J.",
                    "initial": "M.J.",
                    "last": "Levin"
                },
                {
                    "first": "Carrie",
                    "initial": "C.",
                    "last": "Freeman"
                },
                {
                    "first": "Ira",
                    "initial": "I.",
                    "last": "Chalikonda"
                },
                {
                    "first": "Jianjun",
                    "initial": "J.",
                    "last": "Li"
                },
                {
                    "first": "Jeffrey G.",
                    "initial": "J.G.",
                    "last": "Smith"
                },
                {
                    "first": "Michael J.",
                    "initial": "M.J.",
                    "last": "Caulfield"
                },
                {
                    "first": "Jon E.",
                    "initial": "J.E.",
                    "last": "Stek"
                },
                {
                    "first": "Ivan S.F.",
                    "initial": "I.S.F.",
                    "last": "Chan"
                },
                {
                    "first": "Rupert",
                    "initial": "R.",
                    "last": "Vessey"
                },
                {
                    "first": "Florian P.",
                    "initial": "F.P.",
                    "last": "Sch\u00f6del"
                },
                {
                    "first": "Paula W.",
                    "initial": "P.W.",
                    "last": "Annunziato"
                },
                {
                    "first": "Katia",
                    "initial": "K.",
                    "last": "Schlienger"
                },
                {
                    "first": "Jeffrey L.",
                    "initial": "J.L.",
                    "last": "Silber"
                }
            ],
            "doi": "10.1016/j.vaccine.2011.11.096",
            "firstpage": "904",
            "issn": "0264410X",
            "lastpage": "910",
            "pmid": "22154769",
            "pub_year": 2012,
            "title": "Safety, tolerability, and immunogenicity after 1 and 2 doses of zoster vaccine in healthy adults \u226560 years of age",
            "volume": "30"
        },
        "b0210": {
            "authors": [
                {
                    "first": "Timo",
                    "initial": "T.",
                    "last": "Vesikari"
                },
                {
                    "first": "Roland",
                    "initial": "R.",
                    "last": "Hardt"
                },
                {
                    "first": "Hans C.",
                    "initial": "H.C.",
                    "last": "R\u00fcmke"
                },
                {
                    "first": "Giancarlo",
                    "initial": "G.",
                    "last": "Icardi"
                },
                {
                    "first": "Jordi",
                    "initial": "J.",
                    "last": "Montero"
                },
                {
                    "first": "St\u00e9phane",
                    "initial": "S.",
                    "last": "Thomas"
                },
                {
                    "first": "Christine",
                    "initial": "C.",
                    "last": "Sadorge"
                },
                {
                    "first": "Anne",
                    "initial": "A.",
                    "last": "Fiquet"
                }
            ],
            "doi": "10.4161/hv.23412",
            "firstpage": "858",
            "issn": "21645515",
            "lastpage": "864",
            "pmid": "23319176",
            "pub_year": 2013,
            "title": "Immunogenicity and safety of a live attenuated shingles (herpes zoster) vaccine (ZostavaxR) in individuals aged \u2265 70 years: A randomized study of a single dose vs. two different two-dose schedules",
            "volume": "9"
        },
        "b0215": null,
        "b0220": null,
        "b0225": {
            "authors": [
                {
                    "first": "Geert",
                    "initial": "G.",
                    "last": "Leroux-Roels"
                },
                {
                    "first": "Arnaud",
                    "initial": "A.",
                    "last": "Marchant"
                },
                {
                    "first": "Jack",
                    "initial": "J.",
                    "last": "Levy"
                },
                {
                    "first": "Pierre",
                    "initial": "P.",
                    "last": "Van Damme"
                },
                {
                    "first": "Tino F.",
                    "initial": "T.F.",
                    "last": "Schwarz"
                },
                {
                    "first": "Yves",
                    "initial": "Y.",
                    "last": "Horsmans"
                },
                {
                    "first": "Wolfgang",
                    "initial": "W.",
                    "last": "Jilg"
                },
                {
                    "first": "Peter G.",
                    "initial": "P.G.",
                    "last": "Kremsner"
                },
                {
                    "first": "Edwige",
                    "initial": "E.",
                    "last": "Haelterman"
                },
                {
                    "first": "Fr\u00e9d\u00e9ric",
                    "initial": "F.",
                    "last": "Cl\u00e9ment"
                },
                {
                    "first": "Julian J.",
                    "initial": "J.J.",
                    "last": "Gabor"
                },
                {
                    "first": "Meral",
                    "initial": "M.",
                    "last": "Esen"
                },
                {
                    "first": "Annick",
                    "initial": "A.",
                    "last": "Hens"
                },
                {
                    "first": "Isabelle",
                    "initial": "I.",
                    "last": "Carletti"
                },
                {
                    "first": "Laurence",
                    "initial": "L.",
                    "last": "Fissette"
                },
                {
                    "first": "Fernanda",
                    "initial": "F.",
                    "last": "Tavares Da Silva"
                },
                {
                    "first": "Wivine",
                    "initial": "W.",
                    "last": "Burny"
                },
                {
                    "first": "Michel",
                    "initial": "M.",
                    "last": "Janssens"
                },
                {
                    "first": "Philippe",
                    "initial": "P.",
                    "last": "Moris"
                },
                {
                    "first": "Arnaud M.",
                    "initial": "A.M.",
                    "last": "Didierlaurent"
                },
                {
                    "first": "Robbert",
                    "initial": "R.",
                    "last": "Van Der Most"
                },
                {
                    "first": "Nathalie",
                    "initial": "N.",
                    "last": "Gar\u00e7on"
                },
                {
                    "first": "Pascale",
                    "initial": "P.",
                    "last": "Van Belle"
                },
                {
                    "first": "Marcelle",
                    "initial": "M.",
                    "last": "Van Mechelen"
                }
            ],
            "doi": "10.1016/j.clim.2016.05.007",
            "firstpage": "16",
            "issn": "15216616",
            "lastpage": "27",
            "pmid": "27236001",
            "pub_year": 2016,
            "title": "Impact of adjuvants on CD4+ T cell and B cell responses to a protein antigen vaccine: Results from a phase II, randomized, multicenter trial",
            "volume": "169"
        },
        "b0230": null,
        "b0235": {
            "authors": [
                {
                    "first": "Kathleen L.",
                    "initial": "K.L.",
                    "last": "Dooling"
                },
                {
                    "first": "Angela",
                    "initial": "A.",
                    "last": "Guo"
                },
                {
                    "first": "Manisha",
                    "initial": "M.",
                    "last": "Patel"
                },
                {
                    "first": "Grace M.",
                    "initial": "G.M.",
                    "last": "Lee"
                },
                {
                    "first": "Kelly",
                    "initial": "K.",
                    "last": "Moore"
                },
                {
                    "first": "Edward A.",
                    "initial": "E.A.",
                    "last": "Belongia"
                },
                {
                    "first": "Rafael",
                    "initial": "R.",
                    "last": "Harpaz"
                }
            ],
            "doi": "10.15585/mmwr.mm6703a5",
            "firstpage": "103",
            "issn": "01492195",
            "lastpage": "108",
            "pmid": "29370152",
            "pub_year": 2018,
            "title": "Recommendations of the advisory committee on immunization practices for use of herpes zoster vaccines",
            "volume": "67"
        },
        "b0240": null,
        "b0245": null,
        "b0250": null,
        "b0255": null
    },
    "body_text": [
        {
            "endOffset": 54381,
            "parents": [],
            "secId": "s0070",
            "sentence": "Against PHN, VE for RZV (IM) was 23 percentage points and 22 percentage points, respectively, higher than the VE for ZVL (SC) in the previously mentioned age groups.",
            "startOffset": 54216,
            "title": "Discussion"
        },
        {
            "endOffset": 53543,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "NMA results"
                }
            ],
            "secId": "s0065",
            "sentence": "Comparing RZV to placebo (IRR:2.23, 95% CI 2.09, 2.37), ZVL (IM) (IRR:2.05, 95% CI 1.31, 3.18), ZVL (SC) (IRR:2.11, 95% CI 1.96, 2.27), refrigerated ZVL (SC) (IRR:2.38, 95% CI 1.49, 3.79), and an alternative dose of ZVL (SC) (IRR:2.84, 95% CI 1.82, 4.43), there was a statistically significantly higher incidence of systemic reactions (Fig. 5b).",
            "startOffset": 53198,
            "title": "Safety outcomes: Reactogenicity"
        },
        {
            "endOffset": 39597,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "refoffsets": {
                "b0075": {
                    "endOffset": 39404,
                    "startOffset": 39400
                }
            },
            "secId": "s0015",
            "sentence": "Conference abstracts from the 2016 ID Week (IDSA, SHEA, HIVMA, and PIDS joint meeting) [15] were also searched, as this is the major conference for presentation of new vaccine data and it was assumed that anything presented prior to 2016 would be available as a full-text publication.",
            "startOffset": 39313,
            "title": "Systematic literature review"
        },
        {
            "endOffset": 40217,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "For each publication that met the selection criteria, data extraction was performed by one researcher and checked against the original study by an independent researcher.",
            "startOffset": 40047,
            "title": "Systematic literature review"
        },
        {
            "endOffset": 35218,
            "parents": [],
            "secId": "s0005",
            "sentence": "RCTs for ZVL and RZV have compared the efficacy and safety of the respective HZ vaccines versus placebo.",
            "startOffset": 35114,
            "title": "Introduction"
        },
        {
            "endOffset": 55269,
            "parents": [],
            "secId": "s0070",
            "sentence": "In terms of comparisons with formulations available in Canada and the US, RZV (IM) was found to have higher efficacy than ZVL, higher reactogenicity than ZVL and ZVL refrigerated, and safety outcomes comparable with ZVL and ZVL refrigerated.",
            "startOffset": 55028,
            "title": "Discussion"
        },
        {
            "endOffset": 60961,
            "parents": [],
            "secId": "s0070",
            "sentence": "The number of studies for each outcome of interest was relatively small, so the results are limited by the generalizability of the included studies and thus should be interpreted with caution.",
            "startOffset": 60769,
            "title": "Discussion"
        },
        {
            "endOffset": 43960,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The estimated p-scores (probability of an intervention being best) are used to rank all interventions.",
            "startOffset": 43858,
            "title": "Network meta-analysis"
        },
        {
            "endOffset": 35114,
            "parents": [],
            "refoffsets": {
                "b0045": {
                    "endOffset": 35113,
                    "startOffset": 35107
                },
                "b0050": {
                    "endOffset": 35113,
                    "startOffset": 35107
                }
            },
            "secId": "s0005",
            "sentence": "The efficacy and safety of the RZV vaccine has also been demonstrated in two phase III RCTs, ZOster Efficacy in adults aged 50 years and over (ZOE-50) and ZOster Efficacy in adults aged 70 years and over (ZOE-70), which together included approximately 30,000 subjects aged at least 50 years [9,10].",
            "startOffset": 34816,
            "title": "Introduction"
        },
        {
            "endOffset": 36586,
            "parents": [],
            "secId": "s0005",
            "sentence": "Relative effects can then be estimated for all interventions included in the network.",
            "startOffset": 36501,
            "title": "Introduction"
        },
        {
            "endOffset": 63599,
            "parents": [],
            "secId": "s0080",
            "sentence": "AMG, RW, DC, EE, and TM are employees of the GSK group of companies.",
            "startOffset": 63531,
            "title": "Conflict of Interest"
        },
        {
            "endOffset": 50258,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "NMA results"
                }
            ],
            "secId": "s0055",
            "sentence": "Similar results were found for HZ in the group aged \u226570 years, with RZV (IM) also significantly superior to ZVL (SC) (IRR: 0.14; 95% CI 0.09, 0.22) and placebo (IRR:0.09; 95% CI 0.06, 0.13) (Fig. 3b).",
            "startOffset": 50058,
            "title": "Efficacy outcomes"
        },
        {
            "endOffset": 42796,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "In the absence of head-to-head clinical trials directly comparing the two interventions, relative efficacy was examined using NMAs.",
            "startOffset": 42665,
            "title": "Network meta-analysis"
        },
        {
            "endOffset": 51404,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "NMA results"
                }
            ],
            "secId": "s0060",
            "sentence": "One study compared ZVL (SC) with refrigerated ZVL (SC) (available in Canada).",
            "startOffset": 51327,
            "title": "Safety outcomes: Serious adverse events"
        },
        {
            "endOffset": 57729,
            "parents": [],
            "refoffsets": {
                "b0230": {
                    "endOffset": 57728,
                    "startOffset": 57724
                }
            },
            "secId": "s0070",
            "sentence": "However, grade 3 reactogenicity, which occurred in 9.5% of participants, was associated with a transient clinically important decrease in SF-36 Physical Functioning score (affecting activities such as walking, carrying groceries or climbing stairs) on days 1\u20132 after first vaccination [46].",
            "startOffset": 57439,
            "title": "Discussion"
        },
        {
            "endOffset": 32747,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 32746,
                    "startOffset": 32743
                }
            },
            "secId": "s0005",
            "sentence": "Infection with varicella zoster virus (VZV) causes chickenpox in children, and can reappear in adults as herpes zoster (HZ), also known as shingles [1].",
            "startOffset": 32595,
            "title": "Introduction"
        },
        {
            "endOffset": 64231,
            "parents": [],
            "secId": "s0080",
            "sentence": "At the time the study was conducted, HB was also an employee of Mapi BV and is now an employee of Evidera.",
            "startOffset": 64125,
            "title": "Conflict of Interest"
        },
        {
            "endOffset": 53198,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "NMA results"
                }
            ],
            "secId": "s0065",
            "sentence": "RZV (IM) had slightly higher numerical incidence of injection-site reactions than full-dose ZVL (ID) (IRR:1.47, 95% CI 0.56, 3.83) and an alternative dose of ZVL (SC) (IRR:2.25; 95% CI 0.97, 5.25) but the differences were not statistically significant (Fig. 5a).",
            "startOffset": 52936,
            "title": "Safety outcomes: Reactogenicity"
        },
        {
            "endOffset": 33231,
            "parents": [],
            "secId": "s0005",
            "sentence": "The administration of HZ vaccines to older individuals can boost VZV-specific immunological memory and in turn, prevent viral reactivation and HZ development.",
            "startOffset": 33073,
            "title": "Introduction"
        },
        {
            "endOffset": 39963,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Full-text review was conducted by two independent researchers in a double-blind process and all discrepancies were judged by a third reviewer.",
            "startOffset": 39821,
            "title": "Systematic literature review"
        },
        {
            "endOffset": 47601,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0040",
            "sentence": "The NMA was not found to be feasible for the efficacy outcomes in the \u226550 years old population because age is an effect modifier, age was imbalanced between the studies, and the limited number of available studies made it impractical to control for age.",
            "startOffset": 47348,
            "title": "NMA feasibility assessment"
        },
        {
            "endOffset": 52367,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "NMA results"
                }
            ],
            "refoffsets": {
                "b0025": {
                    "endOffset": 52102,
                    "startOffset": 52094
                },
                "b0030": {
                    "endOffset": 52102,
                    "startOffset": 52094
                },
                "b0045": {
                    "endOffset": 52047,
                    "startOffset": 52041
                },
                "b0050": {
                    "endOffset": 52047,
                    "startOffset": 52041
                },
                "b0120": {
                    "endOffset": 52294,
                    "startOffset": 52290
                },
                "b0140": {
                    "endOffset": 52219,
                    "startOffset": 52215
                },
                "b0145": {
                    "endOffset": 52366,
                    "startOffset": 52362
                },
                "b0180": {
                    "endOffset": 52102,
                    "startOffset": 52094
                },
                "b0210": {
                    "endOffset": 52171,
                    "startOffset": 52167
                }
            },
            "secId": "s0065",
            "sentence": "For injection site reactions, two studies compared RZV (IM) with placebo [9,10], three studies compared ZVL (SC) with placebo [5,6,36], one study compared ZVL (SC) to an alternative dose of ZVL (SC) [42], one study compared ZVL (SC) with ZVL (IM) [28], one study compared ZVL (SC) to a full dose of ZVL (intradermal [ID]) [24], and one study compared frozen ZVL (SC) with refrigerated ZVL (SC) [29].",
            "startOffset": 51968,
            "title": "Safety outcomes: Reactogenicity"
        },
        {
            "endOffset": 57438,
            "parents": [],
            "secId": "s0070",
            "sentence": "A recent study of RZV demonstrated that no clinically meaningful reductions in overall mean Short Form 36 (SF-36) Physical Functioning scores were observed after RZV dose 1.",
            "startOffset": 57265,
            "title": "Discussion"
        },
        {
            "endOffset": 61429,
            "parents": [],
            "secId": "s0070",
            "sentence": "This was mainly a consequence of substantial between-study heterogeneity, which was taken into account in the random effects models (e.g. in the NMA of injection-site reactions).",
            "startOffset": 61251,
            "title": "Discussion"
        },
        {
            "endOffset": 34661,
            "parents": [],
            "secId": "s0005",
            "sentence": "It is a non-live adjuvanted subunit vaccine combining glycoprotein E, a protein found on the surface of VZV, with an adjuvant system AS01B that is intended to enhance the immunological response to the glycoprotein E antigen.",
            "startOffset": 34437,
            "title": "Introduction"
        },
        {
            "endOffset": 35505,
            "parents": [],
            "refoffsets": {
                "b0055": {
                    "endOffset": 35504,
                    "startOffset": 35500
                }
            },
            "secId": "s0005",
            "sentence": "A Cochrane systematic literature review (SLR) published in 2016 reviewed 13 RCTs comparing HZ vaccines with placebo or no vaccine, but did not compare the ZVL and RZV vaccines [11].",
            "startOffset": 35324,
            "title": "Introduction"
        },
        {
            "endOffset": 58195,
            "parents": [],
            "refoffsets": {
                "b0235": {
                    "endOffset": 58194,
                    "startOffset": 58190
                }
            },
            "secId": "s0070",
            "sentence": "The US Advisory Committee on Immunization Practices (ACIP) meeting in October 2017 recommended the use of RZV for the prevention of HZ in adults aged \u226550 years, including in people who had previously received ZVL, and recommended RZV for preferential use over ZVL owing to its higher efficacy [47].",
            "startOffset": 57897,
            "title": "Discussion"
        },
        {
            "endOffset": 43132,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "refoffsets": {
                "b0105": {
                    "endOffset": 43131,
                    "startOffset": 43127
                }
            },
            "secId": "s0025",
            "sentence": "NMAs were conducted using a frequentist approach based on weighted regression models whereby larger studies which have smaller standard errors are given more weight than the smaller ones [21].",
            "startOffset": 42940,
            "title": "Network meta-analysis"
        },
        {
            "endOffset": 60664,
            "parents": [],
            "secId": "s0070",
            "sentence": "These larger studies provided a substantial sample size with tens of thousands of patients, resulting in sufficient statistical power to detect possible differences between interventions.",
            "startOffset": 60477,
            "title": "Discussion"
        },
        {
            "endOffset": 61959,
            "parents": [],
            "refoffsets": {
                "b0215": {
                    "endOffset": 61958,
                    "startOffset": 61954
                }
            },
            "secId": "s0070",
            "sentence": "The need for data from a larger population collected outside a research setting, particularly for ethnic minorities, was discussed at ACIP [43].",
            "startOffset": 61815,
            "title": "Discussion"
        },
        {
            "endOffset": 45451,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "refoffsets": {
                "b0115": {
                    "endOffset": 45450,
                    "startOffset": 45446
                }
            },
            "secId": "s0025",
            "sentence": "The frequentist NMA was conducted using the R package netmeta [23].",
            "startOffset": 45384,
            "title": "Network meta-analysis"
        },
        {
            "endOffset": 59123,
            "parents": [],
            "refoffsets": {
                "b0070": {
                    "endOffset": 59122,
                    "startOffset": 59118
                }
            },
            "secId": "s0070",
            "sentence": "Additionally, the results of the present analysis are aligned with the results from a recently published NMA on the efficacy, effectiveness, and safety of HZ vaccines [14].",
            "startOffset": 58951,
            "title": "Discussion"
        },
        {
            "endOffset": 60384,
            "parents": [],
            "secId": "s0070",
            "sentence": "This study was based on a SLR conducted according to PRISMA and Cochrane Collaboration guidelines and recommendations, which provided a robust evidence base for the analysis.",
            "startOffset": 60210,
            "title": "Discussion"
        },
        {
            "endOffset": 61151,
            "parents": [],
            "secId": "s0070",
            "sentence": "The small number of studies may also have had an impact on the estimates generated by the NMA (for example, the different results for PHN in people aged \u226570 years for VE compared with IRR).",
            "startOffset": 60962,
            "title": "Discussion"
        },
        {
            "endOffset": 46420,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "The only HZ vaccines evaluated were RZV (n = 6), ZVL (n = 14), and the live attenuated Oka varicella vaccine manufactured by the Research Foundation for Microbial Diseases of Osaka University (BIKEN) (n = 1), although different formulations and routes of administration were included.",
            "startOffset": 46136,
            "title": "Systematic literature review"
        },
        {
            "endOffset": 35878,
            "parents": [],
            "refoffsets": {
                "b0060": {
                    "endOffset": 35877,
                    "startOffset": 35873
                }
            },
            "secId": "s0005",
            "sentence": "Preliminary data from one study, published as an abstract, compared the immunogenicity of the ZVL and RZV vaccines and reported higher cell-mediated immunity (CMI) responses for the RZV vaccine than the ZVL vaccine, but did not report on clinical efficacy or safety [12].",
            "startOffset": 35607,
            "title": "Introduction"
        },
        {
            "endOffset": 51817,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "NMA results"
                }
            ],
            "secId": "s0060",
            "sentence": "There were no statistically significant differences between any of the interventions.",
            "startOffset": 51732,
            "title": "Safety outcomes: Serious adverse events"
        },
        {
            "endOffset": 57127,
            "parents": [],
            "refoffsets": {
                "b0215": {
                    "endOffset": 57126,
                    "startOffset": 57119
                },
                "b0220": {
                    "endOffset": 57126,
                    "startOffset": 57119
                }
            },
            "secId": "s0070",
            "sentence": "The increased reactogenicity is thought to be associated with the adjuvant, which increases the overall immune response to the antigen [43,44].",
            "startOffset": 56984,
            "title": "Discussion"
        },
        {
            "endOffset": 55774,
            "parents": [],
            "secId": "s0070",
            "sentence": "This may reflect standard error approximation assuming normally distributed data, and the use of direct rather than indirect comparisons for VE when compared to IRR.",
            "startOffset": 55609,
            "title": "Discussion"
        },
        {
            "endOffset": 59317,
            "parents": [],
            "secId": "s0070",
            "sentence": "In the NMA by Tricco et al., RZV was found to be statistically superior compared to ZVL (VE = 85%, 95% credible interval (CrI): 31%, 98%) in terms of protection against laboratory-confirmed HZ.",
            "startOffset": 59124,
            "title": "Discussion"
        },
        {
            "endOffset": 52652,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "NMA results"
                }
            ],
            "secId": "s0065",
            "sentence": "Results from the network meta-analysis are shown in Fig. 5 and Table 4.",
            "startOffset": 52581,
            "title": "Safety outcomes: Reactogenicity"
        },
        {
            "endOffset": 61814,
            "parents": [],
            "secId": "s0070",
            "sentence": "This is a common issue with RCTs, and is not specifically related to the present analysis.",
            "startOffset": 61724,
            "title": "Discussion"
        },
        {
            "endOffset": 54517,
            "parents": [],
            "secId": "s0070",
            "sentence": "Similar results were reported for IRR in three of the four efficacy outcomes (HZ in both age groups and PHN in subjects aged \u226560 years).",
            "startOffset": 54381,
            "title": "Discussion"
        },
        {
            "endOffset": 47914,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0040",
            "sentence": "Additionally, a number of key decisions were made at this stage including: excluding trials that were not connected to the network or not approved for use in the population of interest; pooling age subgroups for the SAE and reactogenicity outcomes; and pooling safety outcomes on the basis of follow-up duration.",
            "startOffset": 47602,
            "title": "NMA feasibility assessment"
        },
        {
            "endOffset": 53854,
            "parents": [],
            "secId": "s0070",
            "sentence": "NMA was conducted on networks for efficacy and safety outcomes for which evidence was available, using a frequentist approach.",
            "startOffset": 53728,
            "title": "Discussion"
        },
        {
            "endOffset": 33388,
            "parents": [],
            "secId": "s0005",
            "sentence": "Two zoster vaccines are currently available in the United States (US) and Canada, Zoster Vaccine Live (ZVL) and adjuvanted Recombinant Zoster Vaccine (RZV).",
            "startOffset": 33232,
            "title": "Introduction"
        },
        {
            "endOffset": 33905,
            "parents": [],
            "refoffsets": {
                "b0020": {
                    "endOffset": 33904,
                    "startOffset": 33901
                }
            },
            "secId": "s0005",
            "sentence": "ZVL is administered as a single dose [4].",
            "startOffset": 33864,
            "title": "Introduction"
        },
        {
            "endOffset": 38802,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "There were no restrictions on publication date or language.",
            "startOffset": 38743,
            "title": "Systematic literature review"
        },
        {
            "endOffset": 41747,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Differences in age were accounted for by splitting the data into age groups of \u226560 and \u226570 years of age, respectively.",
            "startOffset": 41629,
            "title": "Network meta-analysis feasibility assessment"
        },
        {
            "endOffset": 45384,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "For details of the decision rules applied in selecting studies for the analysis, see Supplementary File S3.",
            "startOffset": 45277,
            "title": "Network meta-analysis"
        },
        {
            "endOffset": 34042,
            "parents": [],
            "secId": "s0005",
            "sentence": "The efficacy and safety of the ZVL vaccine has been demonstrated in two phase III placebo-controlled randomised controlled trials (RCT).",
            "startOffset": 33906,
            "title": "Introduction"
        },
        {
            "endOffset": 47347,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0040",
            "sentence": "The feasibility assessment concluded that NMA was feasible for efficacy outcomes (incidence of HZ and PHN, stratified into age \u226560 years and age \u226570 years subgroups), SAEs and reactogenicity (injection-site reactions, systemic reactions) (each in the population aged \u226550 years).",
            "startOffset": 47069,
            "title": "NMA feasibility assessment"
        },
        {
            "endOffset": 42939,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Efficacy outcomes were examined in terms of vaccine efficacy (VE) and incidence rate ratios (IRRs), and safety outcomes were examined as IRRs.",
            "startOffset": 42797,
            "title": "Network meta-analysis"
        },
        {
            "endOffset": 45657,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "A total of 1290 citations were identified from the literature searches, of which 89 were retrieved for full-text screening and 25 were included in the review (Fig. 1).",
            "startOffset": 45490,
            "title": "Systematic literature review"
        },
        {
            "endOffset": 44597,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "With regards to selection of comparator data, selection rules for including or excluding studies from the networks were developed in consultation with statistical and clinical experts, to ensure that patients were not double-counted in cases where multiple publications presented results for a single trial or where pooled data were available for age subgroups of interest.",
            "startOffset": 44224,
            "title": "Network meta-analysis"
        },
        {
            "endOffset": 43304,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "In this type of analysis, the relative effects of each intervention is presented as a point estimate (e.g. VE, IRR) along with corresponding 95% confidence intervals (CI).",
            "startOffset": 43133,
            "title": "Network meta-analysis"
        },
        {
            "endOffset": 60210,
            "parents": [],
            "secId": "s0070",
            "sentence": "Despite these differences, the overall results of the two NMAs have very similar findings.",
            "startOffset": 60120,
            "title": "Discussion"
        },
        {
            "endOffset": 57841,
            "parents": [],
            "secId": "s0070",
            "sentence": "Patient counselling to advise of the anticipated short-term effects of the vaccine may help inform the patient.",
            "startOffset": 57730,
            "title": "Discussion"
        },
        {
            "endOffset": 61552,
            "parents": [],
            "secId": "s0070",
            "sentence": "This tended to increase the corresponding standard errors and therefore the width of the CIs in the random effects models.",
            "startOffset": 61430,
            "title": "Discussion"
        },
        {
            "endOffset": 48556,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "NMA results"
                }
            ],
            "secId": "s0055",
            "sentence": "For efficacy outcomes, evidence was only available to compare two vaccines, intramuscular (IM) RZV and subcutaneous (SC) ZVL.",
            "startOffset": 48431,
            "title": "Efficacy outcomes"
        },
        {
            "endOffset": 39064,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The primary search was conducted on 7 March 2017 in MEDLINE, MEDLINE in Process, EMBASE, and Cochrane Central Registry of Controlled Trials (CENTRAL) simultaneously, using Ovid and included studies published before 7 March 2017.",
            "startOffset": 38836,
            "title": "Systematic literature review"
        },
        {
            "endOffset": 48065,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0040",
            "sentence": "As the study examining the BIKEN vaccine was not connected to the network, it was removed at this stage and no analyses were conducted using its data.",
            "startOffset": 47915,
            "title": "NMA feasibility assessment"
        },
        {
            "endOffset": 58783,
            "parents": [],
            "secId": "s0070",
            "sentence": "The results of the present analysis are in line with the recommendations by ACIP, NACI, and the CIQ as the benefit-risk profile appears more favourable for RZV compared with ZVL.",
            "startOffset": 58605,
            "title": "Discussion"
        },
        {
            "endOffset": 36329,
            "parents": [],
            "refoffsets": {
                "b0065": {
                    "endOffset": 36328,
                    "startOffset": 36324
                }
            },
            "secId": "s0005",
            "sentence": "In the absence of head-to-head clinical trials directly comparing the two interventions, relative efficacy can be investigated by using the technique of network meta-analysis (NMA), an extension of traditional pair-wise meta-analysis [13].",
            "startOffset": 36090,
            "title": "Introduction"
        },
        {
            "endOffset": 62748,
            "parents": [],
            "secId": "s0075",
            "sentence": "The results of this analysis suggested that RZV had significantly higher VE against HZ and PHN in both age groups studied (aged \u226560 years and \u226570 years).",
            "startOffset": 62595,
            "title": "Conclusion"
        },
        {
            "endOffset": 60476,
            "parents": [],
            "refoffsets": {
                "b0025": {
                    "endOffset": 60475,
                    "startOffset": 60465
                },
                "b0030": {
                    "endOffset": 60475,
                    "startOffset": 60465
                },
                "b0045": {
                    "endOffset": 60475,
                    "startOffset": 60465
                },
                "b0050": {
                    "endOffset": 60475,
                    "startOffset": 60465
                }
            },
            "secId": "s0070",
            "sentence": "The largest studies in the analysis were RCTs comparing RZV or ZVL with placebo [5,6,9,10].",
            "startOffset": 60385,
            "title": "Discussion"
        },
        {
            "endOffset": 44224,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Heterogeneity features are demonstrated in terms of Cochran\u2019s Q-statistic and I2, however, these should be interpreted with care when applied to small networks.",
            "startOffset": 44064,
            "title": "Network meta-analysis"
        },
        {
            "endOffset": 38262,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Outcomes: Efficacy outcomes included: incidence of HZ (full duration of follow-up or repeated measures); incidence of PHN (full duration of follow-up); incidence of other HZ complications such as HZ ophthalmicus, and visceral, dermatologic, neurologic/neurovascular conditions at last assessed follow-up; and HZ burden of illness mean score.",
            "startOffset": 37921,
            "title": "Systematic literature review"
        },
        {
            "endOffset": 39820,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "For publications assessed as potentially relevant, full-text articles were obtained and evaluated against the selection criteria.",
            "startOffset": 39691,
            "title": "Systematic literature review"
        },
        {
            "endOffset": 43429,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "For the efficacy outcomes, only fixed-effect frequentist NMA models were run due to the limited number of studies available.",
            "startOffset": 43305,
            "title": "Network meta-analysis"
        },
        {
            "endOffset": 42641,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Overall, we ensured that only similar study data were pooled, applying the measures described above.",
            "startOffset": 42541,
            "title": "Network meta-analysis feasibility assessment"
        },
        {
            "endOffset": 53653,
            "parents": [],
            "secId": "s0070",
            "sentence": "A total of 25 publications relating to 21 RCTs were identified by a SLR and included in the review.",
            "startOffset": 53554,
            "title": "Discussion"
        },
        {
            "endOffset": 38836,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Only human studies were included.",
            "startOffset": 38803,
            "title": "Systematic literature review"
        },
        {
            "endOffset": 51564,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "NMA results"
                }
            ],
            "secId": "s0060",
            "sentence": "Fig. 4 and Table 3 show the NMA results for the analysis of SAEs over \u226442 days of follow-up (Fig. 4a) and SAEs over the longest duration of follow-up (Fig. 4b).",
            "startOffset": 51404,
            "title": "Safety outcomes: Serious adverse events"
        },
        {
            "endOffset": 46070,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "The key characteristics of the included studies are summarised in Table 1.",
            "startOffset": 45996,
            "title": "Systematic literature review"
        },
        {
            "endOffset": 50446,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "NMA results"
                }
            ],
            "secId": "s0055",
            "sentence": "RZV (IM) was also statistically significantly better than ZVL (SC) (IRR:0.32; 95% CI 0.10, 0.97) and placebo (IRR:0.11; 95% CI 0.04, 0.30) against PHN in subjects aged \u226560 years (Fig. 3c).",
            "startOffset": 50258,
            "title": "Efficacy outcomes"
        },
        {
            "endOffset": 55608,
            "parents": [],
            "secId": "s0070",
            "sentence": "The assessment of statistical significance for the difference between RZV (IM) and ZVL (SC) for PHN in subjects aged \u226570 years resulted in different conclusions for the VE analysis (statistically significant difference, as the 95% CI did not include zero) compared with the IRR analysis (difference did not reach statistical significance).",
            "startOffset": 55269,
            "title": "Discussion"
        },
        {
            "endOffset": 50841,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "NMA results"
                }
            ],
            "secId": "s0060",
            "sentence": "Evidence was available to compare safety outcomes for RZV (IM) and several formulations and routes of ZVL.",
            "startOffset": 50735,
            "title": "Safety outcomes: Serious adverse events"
        },
        {
            "endOffset": 37738,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Interventions: Interventions included all HZ vaccines, regardless of the dose, schedule, preparation, or route of administration.",
            "startOffset": 37609,
            "title": "Systematic literature review"
        },
        {
            "endOffset": 49377,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "NMA results"
                }
            ],
            "secId": "s0055",
            "sentence": "In both age groups, RZV (IM) had higher VE than ZVL (SC).",
            "startOffset": 49320,
            "title": "Efficacy outcomes"
        },
        {
            "endOffset": 62810,
            "parents": [],
            "secId": "s0075",
            "sentence": "There were no differences in safety between the two vaccines.",
            "startOffset": 62749,
            "title": "Conclusion"
        },
        {
            "endOffset": 38654,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Study Design: Full-text publications and conference abstracts showing results of phase II, III and IV RCTs were included.",
            "startOffset": 38533,
            "title": "Systematic literature review"
        },
        {
            "endOffset": 58499,
            "parents": [],
            "refoffsets": {
                "b0220": {
                    "endOffset": 58498,
                    "startOffset": 58494
                }
            },
            "secId": "s0070",
            "sentence": "Additionally, the Canadian National Advisory Committee on Immunization (NACI) provided a strong recommendation that RZV should be offered to populations \u226550 years of age without contraindications as well as to populations \u226550 years of age without contraindications who have previously received ZVL [44].",
            "startOffset": 58196,
            "title": "Discussion"
        },
        {
            "endOffset": 48190,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0040",
            "sentence": "Expert opinion considered placebo to be an appropriate common comparator despite differences in the route of administration.",
            "startOffset": 48066,
            "title": "NMA feasibility assessment"
        },
        {
            "endOffset": 63690,
            "parents": [],
            "secId": "s0080",
            "sentence": "BS and LO were employed by the GSK group of companies at the time the study was conducted.",
            "startOffset": 63600,
            "title": "Conflict of Interest"
        },
        {
            "endOffset": 53727,
            "parents": [],
            "secId": "s0070",
            "sentence": "Of these, 18 publications relating to 14 trials were included in the NMA.",
            "startOffset": 53654,
            "title": "Discussion"
        },
        {
            "endOffset": 63103,
            "parents": [],
            "secId": "s0075",
            "sentence": "This analysis should further help policy-makers and public health officials to evaluate the different vaccines available for HZ in order to support evidence-based decisions.",
            "startOffset": 62930,
            "title": "Conclusion"
        },
        {
            "endOffset": 40714,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "refoffsets": {
                "b0080": {
                    "endOffset": 40713,
                    "startOffset": 40709
                }
            },
            "secId": "s0015",
            "sentence": "Each study included was assessed for internal (amount of selection, information and confounding bias) and external (generalizability of study results) validity, using the Cochrane Risk of Bias Tool, which has been tested for internal consistency, reliability, and validity [16].",
            "startOffset": 40436,
            "title": "Systematic literature review"
        },
        {
            "endOffset": 63724,
            "parents": [],
            "secId": "s0080",
            "sentence": "LO is now employed by CureVac AG.",
            "startOffset": 63691,
            "title": "Conflict of Interest"
        },
        {
            "endOffset": 59534,
            "parents": [],
            "secId": "s0070",
            "sentence": "The NMA also found RZV to be associated with more adverse events at the injection site compared to ZVL (Relative Risk (RR) = 1.79, 95%CrI: 1.05, 2.34) and more systemic adverse events (RR = 2.28, 95%CrI: 1.45, 3.65).",
            "startOffset": 59318,
            "title": "Discussion"
        },
        {
            "endOffset": 62929,
            "parents": [],
            "secId": "s0075",
            "sentence": "As may be anticipated for an adjuvanted vaccine, RZV was associated with significantly higher reactogenicity than ZVL.",
            "startOffset": 62811,
            "title": "Conclusion"
        },
        {
            "endOffset": 37209,
            "parents": [],
            "secId": "s0005",
            "sentence": "The objective of the present study was to evaluate the relative efficacy and safety of HZ vaccines in adults aged 50 years or older using a NMA based on evidence from published RCTs.",
            "startOffset": 37027,
            "title": "Introduction"
        },
        {
            "endOffset": 63420,
            "parents": [],
            "secId": "s0075",
            "sentence": "These results should be confirmed in the future as further data, such as studies conducted in real-life settings, become available.",
            "startOffset": 63289,
            "title": "Conclusion"
        },
        {
            "endOffset": 40342,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Data on study and patient characteristics were extracted in order to evaluate the comparability of the studies and patients.",
            "startOffset": 40218,
            "title": "Systematic literature review"
        },
        {
            "endOffset": 40975,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "refoffsets": {
                "b0085": {
                    "endOffset": 40851,
                    "startOffset": 40847
                },
                "b0090": {
                    "endOffset": 40974,
                    "startOffset": 40970
                }
            },
            "secId": "s0020",
            "sentence": "The feasibility of conducting a valid NMA was evaluated using a standardized approach [17], in order to determine if there were sufficient data for analysis and to ensure that the transitivity assumption held [18].",
            "startOffset": 40761,
            "title": "Network meta-analysis feasibility assessment"
        },
        {
            "endOffset": 43857,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "For frequentist analyses, point estimates reflect the average relative effect observed, while 95% CIs reflect the frequency (i.e., the proportion) of CIs that contain the true value in a hypothetical repeated experiment.",
            "startOffset": 43637,
            "title": "Network meta-analysis"
        },
        {
            "endOffset": 49079,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "NMA results"
                }
            ],
            "secId": "s0055",
            "sentence": "The difference between the VE of RZV (IM) and the VE of ZVL (SC) was 0.41 (95% CI 0.34, 0.47) in subjects aged \u226560 years and 0.54 (95% CI 0.43, 0.65) in subjects aged \u226570 years, indicating that the VE of RZV (IM) was 41 percentage points and 54 percentage points higher than the VE of ZVL (SC) in subjects aged \u226560 years and \u226570 years, respectively.",
            "startOffset": 48730,
            "title": "Efficacy outcomes"
        },
        {
            "endOffset": 49877,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "NMA results"
                }
            ],
            "secId": "s0055",
            "sentence": "Fig. 3 shows the efficacy results for HZ and PHN in both age groups presented in terms of the IRR.",
            "startOffset": 49779,
            "title": "Efficacy outcomes"
        },
        {
            "endOffset": 41966,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "refoffsets": {
                "b0095": {
                    "endOffset": 41906,
                    "startOffset": 41902
                },
                "b0100": {
                    "endOffset": 41965,
                    "startOffset": 41961
                }
            },
            "secId": "s0020",
            "sentence": "Differences in race were not relevant since the two studies on exclusively Japanese participants were excluded due to being disconnected from the network [19] or not approved for use in the population of interest [20].",
            "startOffset": 41748,
            "title": "Network meta-analysis feasibility assessment"
        },
        {
            "endOffset": 57264,
            "parents": [],
            "refoffsets": {
                "b0225": {
                    "endOffset": 57263,
                    "startOffset": 57259
                }
            },
            "secId": "s0070",
            "sentence": "Both higher immunogenicity and more frequent injection-site pain have been associated with this adjuvant type in previous research [45].",
            "startOffset": 57128,
            "title": "Discussion"
        },
        {
            "endOffset": 43636,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "For the safety outcomes, slightly more data were available and therefore both fixed- and random-effects frequentist NMA models were used, with the final model selected based on model heterogeneity features.",
            "startOffset": 43430,
            "title": "Network meta-analysis"
        },
        {
            "endOffset": 59709,
            "parents": [],
            "secId": "s0070",
            "sentence": "However, the methodology between these two NMAs are slightly different with Tricco et al. utilizing a Bayesian approach and the present analysis using a frequentist approach.",
            "startOffset": 59535,
            "title": "Discussion"
        },
        {
            "endOffset": 52441,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "NMA results"
                }
            ],
            "secId": "s0065",
            "sentence": "Details of the preparations used in each study are summarised in Table 1.",
            "startOffset": 52368,
            "title": "Safety outcomes: Reactogenicity"
        },
        {
            "endOffset": 33072,
            "parents": [],
            "refoffsets": {
                "b0015": {
                    "endOffset": 33071,
                    "startOffset": 33068
                }
            },
            "secId": "s0005",
            "sentence": "Treatment for HZ is complex and only partially effective, while interventions to prevent HZ have potential to reduce the burden of HZ and PHN [3].",
            "startOffset": 32926,
            "title": "Introduction"
        },
        {
            "endOffset": 49319,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "NMA results"
                }
            ],
            "secId": "s0055",
            "sentence": "Fig. 2 also shows the results for VE against PHN in subjects aged \u226560 years (Fig. 2c) and aged \u226570 years (Fig. 2d).",
            "startOffset": 49204,
            "title": "Efficacy outcomes"
        },
        {
            "endOffset": 42540,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Of note, the degree of severity of the safety outcomes for reactogenicity was not included in the analysis, only the incidence.",
            "startOffset": 42413,
            "title": "Network meta-analysis feasibility assessment"
        },
        {
            "endOffset": 54682,
            "parents": [],
            "secId": "s0070",
            "sentence": "For one of the efficacy outcomes, PHN in subjects aged \u226570 years, the difference in IRR was not statistically significantly different between RZV (IM) and ZVL (SC).",
            "startOffset": 54518,
            "title": "Discussion"
        },
        {
            "endOffset": 50691,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "NMA results"
                }
            ],
            "secId": "s0055",
            "sentence": "In subjects aged \u226570 years, the IRR for PHN for RZV (IM) was statistically significantly better than placebo (IRR:0.11; 95% CI 0.04, 0.31), but was not statistically significantly different from ZVL (SC) (IRR:0.34; 95% CI 0.11, 1.06) (Fig. 3d).",
            "startOffset": 50447,
            "title": "Efficacy outcomes"
        },
        {
            "endOffset": 48409,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "NMA results"
                }
            ],
            "secId": "s0050",
            "sentence": "The networks and input data for each outcome analysed in the NMA are shown in Supplementary File S6.",
            "startOffset": 48309,
            "title": "Networks and input data"
        },
        {
            "endOffset": 36500,
            "parents": [],
            "secId": "s0005",
            "sentence": "Provided that all the published trials have at least one intervention in common with another, a network can be constructed linking the interventions tested in each trial.",
            "startOffset": 36330,
            "title": "Introduction"
        },
        {
            "endOffset": 45276,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The number of patients receiving only one dose was small; in the ZOE-50 trial, 95.6% of RZV recipients and 96.4% of placebo recipients received both doses, and in the ZOE-70 trial, 94.4% of RZV recipients and 95.6% of placebo recipients received both doses.",
            "startOffset": 45019,
            "title": "Network meta-analysis"
        },
        {
            "endOffset": 37608,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Studies conducted in immunocompromised patients were excluded.",
            "startOffset": 37546,
            "title": "Systematic literature review"
        },
        {
            "endOffset": 62117,
            "parents": [],
            "refoffsets": {
                "b0255": {
                    "endOffset": 62116,
                    "startOffset": 62112
                }
            },
            "secId": "s0070",
            "sentence": "While there have been 7 studies examining the real world effectiveness of ZVL, future research evaluating the real world effectiveness of RZV is needed [51].",
            "startOffset": 61960,
            "title": "Discussion"
        },
        {
            "endOffset": 40436,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "For outcomes, data were extracted from the text or tables in the publication where available.",
            "startOffset": 40343,
            "title": "Systematic literature review"
        },
        {
            "endOffset": 58951,
            "parents": [],
            "refoffsets": {
                "b0245": {
                    "endOffset": 58896,
                    "startOffset": 58892
                },
                "b0250": {
                    "endOffset": 58950,
                    "startOffset": 58946
                }
            },
            "secId": "s0070",
            "sentence": "Similarly, the German Standing Committee on Vaccination (STIKO) did not recommend ZVL as a standard vaccine [49] but did recommend RZV in adults \u226560 years of age [50].",
            "startOffset": 58784,
            "title": "Discussion"
        },
        {
            "endOffset": 32926,
            "parents": [],
            "refoffsets": {
                "b0010": {
                    "endOffset": 32872,
                    "startOffset": 32869
                },
                "b0015": {
                    "endOffset": 32925,
                    "startOffset": 32922
                }
            },
            "secId": "s0005",
            "sentence": "Post-herpetic neuralgia (PHN) is a common complication of HZ, characterised by constant, severe stabbing or burning pain [2] that adversely affects patients\u2019 quality of life [3].",
            "startOffset": 32748,
            "title": "Introduction"
        },
        {
            "endOffset": 60768,
            "parents": [],
            "secId": "s0070",
            "sentence": "However, the study has some limitations that should be taken into account when considering the findings.",
            "startOffset": 60664,
            "title": "Discussion"
        },
        {
            "endOffset": 45996,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0025": {
                    "endOffset": 45995,
                    "startOffset": 45973
                },
                "b0030": {
                    "endOffset": 45995,
                    "startOffset": 45973
                },
                "b0045": {
                    "endOffset": 45995,
                    "startOffset": 45973
                },
                "b0050": {
                    "endOffset": 45995,
                    "startOffset": 45973
                },
                "b0095": {
                    "endOffset": 45995,
                    "startOffset": 45973
                },
                "b0100": {
                    "endOffset": 45995,
                    "startOffset": 45973
                },
                "b0120": {
                    "endOffset": 45995,
                    "startOffset": 45973
                },
                "b0125": {
                    "endOffset": 45995,
                    "startOffset": 45973
                },
                "b0130": {
                    "endOffset": 45995,
                    "startOffset": 45973
                },
                "b0135": {
                    "endOffset": 45995,
                    "startOffset": 45973
                },
                "b0140": {
                    "endOffset": 45995,
                    "startOffset": 45973
                },
                "b0145": {
                    "endOffset": 45995,
                    "startOffset": 45973
                },
                "b0150": {
                    "endOffset": 45995,
                    "startOffset": 45973
                },
                "b0155": {
                    "endOffset": 45995,
                    "startOffset": 45973
                },
                "b0160": {
                    "endOffset": 45995,
                    "startOffset": 45973
                },
                "b0165": {
                    "endOffset": 45995,
                    "startOffset": 45973
                },
                "b0170": {
                    "endOffset": 45995,
                    "startOffset": 45973
                },
                "b0175": {
                    "endOffset": 45995,
                    "startOffset": 45973
                },
                "b0180": {
                    "endOffset": 45995,
                    "startOffset": 45973
                },
                "b0185": {
                    "endOffset": 45995,
                    "startOffset": 45973
                },
                "b0190": {
                    "endOffset": 45995,
                    "startOffset": 45973
                },
                "b0195": {
                    "endOffset": 45995,
                    "startOffset": 45973
                },
                "b0200": {
                    "endOffset": 45995,
                    "startOffset": 45973
                },
                "b0205": {
                    "endOffset": 45995,
                    "startOffset": 45973
                },
                "b0210": {
                    "endOffset": 45995,
                    "startOffset": 45973
                }
            },
            "secId": "s0035",
            "sentence": "The 25 publications related to 21 trials, and included 21 full-text publications and 4 conference abstracts [5,6,9,10,19,20,24\u201342].",
            "startOffset": 45865,
            "title": "Systematic literature review"
        },
        {
            "endOffset": 37920,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Comparators: Comparators included other HZ vaccines, placebo or no intervention (including studies evaluating different doses, schedules, preparations, or routes of administration).",
            "startOffset": 37739,
            "title": "Systematic literature review"
        },
        {
            "endOffset": 49685,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "NMA results"
                }
            ],
            "secId": "s0055",
            "sentence": "The difference between the VE of RZV (IM) and the VE of ZVL (SC) was 0.23 (95% CI 0.09, 0.37) and 0.22 (95% CI 0.07, 0.37), respectively, indicating that VE for RZV (IM) was 23 percentage points and 22 percentage points higher than the VE for ZVL (SC) in subjects aged \u226560 years and \u226570 years, respectively.",
            "startOffset": 49378,
            "title": "Efficacy outcomes"
        },
        {
            "endOffset": 46775,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "Of the 14 trials on ZVL, the SPS study also had the longest duration (over 3 years) followed by the ZEST trial (mean of 1.3 years).",
            "startOffset": 46644,
            "title": "Systematic literature review"
        },
        {
            "endOffset": 55027,
            "parents": [],
            "secId": "s0070",
            "sentence": "RZV (IM) was associated with a statistically significantly higher incidence of injection-site reactions and systemic reactions compared with placebo or most formulations of ZVL.",
            "startOffset": 54850,
            "title": "Discussion"
        },
        {
            "endOffset": 54034,
            "parents": [],
            "secId": "s0070",
            "sentence": "The results of the analysis showed that RZV (IM) had statistically significantly higher VE than ZVL (SC) against HZ and PHN in subjects aged \u226560 years and subjects aged \u226570 years.",
            "startOffset": 53855,
            "title": "Discussion"
        },
        {
            "endOffset": 45018,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "refoffsets": {
                "b0110": {
                    "endOffset": 45017,
                    "startOffset": 45013
                }
            },
            "secId": "s0025",
            "sentence": "For safety of RZV, the total vaccinated cohort was used, as per ICH guidelines, so some patients had received only one dose [22].",
            "startOffset": 44889,
            "title": "Network meta-analysis"
        },
        {
            "endOffset": 48267,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0040",
            "sentence": "Details of the feasibility assessment are provided in Supplementary File S5.",
            "startOffset": 48191,
            "title": "NMA feasibility assessment"
        },
        {
            "endOffset": 49779,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "NMA results"
                }
            ],
            "secId": "s0055",
            "sentence": "The VE was statistically significantly different between the two vaccines in both age groups.",
            "startOffset": 49686,
            "title": "Efficacy outcomes"
        },
        {
            "endOffset": 33863,
            "parents": [],
            "refoffsets": {
                "b0020": {
                    "endOffset": 33862,
                    "startOffset": 33859
                }
            },
            "secId": "s0005",
            "sentence": "ZVL (Zostavax [frozen] originally licensed in Canada in September 2015 but no longer marketed in Canada and Zostavax II [refrigerated, available in Canada as of licence date May 2014], Merck Sharp and Dohme) is indicated for use in individuals aged 50 years or over and contraindicated for use in immunosuppressed or immunodeficient individuals in whom administration of ZVL may result in disseminated disease [4].",
            "startOffset": 33449,
            "title": "Introduction"
        },
        {
            "endOffset": 38742,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Full details of the PICOS selection criteria used are provided in Supplementary File S1.",
            "startOffset": 38654,
            "title": "Systematic literature review"
        },
        {
            "endOffset": 64124,
            "parents": [],
            "secId": "s0080",
            "sentence": "AT, KH, XW and RN are employees of ICON Plc, previously Mapi BV, which received payment from the GSK group of companies to conduct this research.",
            "startOffset": 63979,
            "title": "Conflict of Interest"
        },
        {
            "endOffset": 35606,
            "parents": [],
            "secId": "s0005",
            "sentence": "Further, this review was published before both the clinical efficacy studies for RZV were available.",
            "startOffset": 35506,
            "title": "Introduction"
        },
        {
            "endOffset": 42216,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "We accounted for differences in follow-up time by suitable methodology (e.g. by considering person-years at risk and number of events in a model for count data) and conducted separate analyses for longer duration of follow-up in the safety analyses.",
            "startOffset": 41967,
            "title": "Network meta-analysis feasibility assessment"
        },
        {
            "endOffset": 48729,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "NMA results"
                }
            ],
            "secId": "s0055",
            "sentence": "RZV (IM) had a higher VE than ZVL (SC) in both age groups.",
            "startOffset": 48671,
            "title": "Efficacy outcomes"
        },
        {
            "endOffset": 61250,
            "parents": [],
            "secId": "s0070",
            "sentence": "A further limitation is that the 95% CIs were quite wide for some of the safety outcomes analysed.",
            "startOffset": 61152,
            "title": "Discussion"
        },
        {
            "endOffset": 36090,
            "parents": [],
            "secId": "s0005",
            "sentence": "As such, there is a need for information on the relative efficacy and safety of available HZ vaccines to help support decision-makers and healthcare professionals selecting optimal ways to use the interventions.",
            "startOffset": 35879,
            "title": "Introduction"
        },
        {
            "endOffset": 42412,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "For both efficacy and safety outcomes, definitions over the included studies were deemed comparable.",
            "startOffset": 42312,
            "title": "Network meta-analysis feasibility assessment"
        },
        {
            "endOffset": 56146,
            "parents": [],
            "secId": "s0070",
            "sentence": "However, the upper bound of the CI for the IRR analysis was 1.06, only a little above the threshold for statistical significance of 1.0, and the results should be interpreted with caution.",
            "startOffset": 55958,
            "title": "Discussion"
        },
        {
            "endOffset": 35323,
            "parents": [],
            "secId": "s0005",
            "sentence": "To date there have been no head-to-head trials directly comparing the relative efficacy of the vaccines.",
            "startOffset": 35219,
            "title": "Introduction"
        },
        {
            "endOffset": 42311,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Interventions were defined according to mode of application, dose and potential refrigeration.",
            "startOffset": 42217,
            "title": "Network meta-analysis feasibility assessment"
        },
        {
            "endOffset": 37026,
            "parents": [],
            "refoffsets": {
                "b0070": {
                    "endOffset": 37025,
                    "startOffset": 37021
                }
            },
            "secId": "s0005",
            "sentence": "A recent NMA, published while this study was being conducted, compared the efficacy, effectiveness, and safety of HZ vaccines; however, they were not able to evaluate relative PHN efficacy (comparing RZV to ZVL) and did not stratify efficacy results by age which is a known effect modifier of vaccine efficacy (VE) [14].",
            "startOffset": 36706,
            "title": "Introduction"
        },
        {
            "endOffset": 62342,
            "parents": [],
            "secId": "s0070",
            "sentence": "While high compliance was observed in the phase III clinical trials (\u223c95%), data will also be needed on real-world patient adherence with two doses of RZV in routine practice, as distinct from the controlled setting of RCTs.",
            "startOffset": 62118,
            "title": "Discussion"
        },
        {
            "endOffset": 59821,
            "parents": [],
            "secId": "s0070",
            "sentence": "The present analysis also differs by evaluating relative PHN efficacy and presenting results stratified by age.",
            "startOffset": 59710,
            "title": "Discussion"
        },
        {
            "endOffset": 34815,
            "parents": [],
            "refoffsets": {
                "b0040": {
                    "endOffset": 34814,
                    "startOffset": 34811
                }
            },
            "secId": "s0005",
            "sentence": "The primary vaccination schedule for RZV consists of two doses, with the second dose administered at any time between 2 and 6 months after the first [8].",
            "startOffset": 34662,
            "title": "Introduction"
        },
        {
            "endOffset": 37463,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "A literature search was conducted to identify RCTs evaluating the efficacy and safety of HZ vaccines, using Population, Interventions, Comparators, Outcomes and Study Design (PICOS) criteria as follows:",
            "startOffset": 37261,
            "title": "Systematic literature review"
        },
        {
            "endOffset": 37545,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Population: Adults aged 50 years or older, with no history of prior HZ infection.",
            "startOffset": 37464,
            "title": "Systematic literature review"
        },
        {
            "endOffset": 63511,
            "parents": [],
            "secId": "s0075",
            "sentence": "This NMA approach could also be applied to the evaluation of other vaccines in the future.",
            "startOffset": 63421,
            "title": "Conclusion"
        },
        {
            "endOffset": 51252,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "NMA results"
                }
            ],
            "refoffsets": {
                "b0025": {
                    "endOffset": 50940,
                    "startOffset": 50929
                },
                "b0030": {
                    "endOffset": 50940,
                    "startOffset": 50929
                },
                "b0140": {
                    "endOffset": 51127,
                    "startOffset": 51123
                },
                "b0145": {
                    "endOffset": 51251,
                    "startOffset": 51247
                },
                "b0165": {
                    "endOffset": 50940,
                    "startOffset": 50929
                },
                "b0180": {
                    "endOffset": 50940,
                    "startOffset": 50929
                },
                "b0200": {
                    "endOffset": 51186,
                    "startOffset": 51182
                },
                "b0205": {
                    "endOffset": 51079,
                    "startOffset": 51075
                },
                "b0210": {
                    "endOffset": 51009,
                    "startOffset": 51005
                }
            },
            "secId": "s0060",
            "sentence": "Four studies compared ZVL (SC) with placebo [5,6,33,36], one study compared ZVL (SC) to an alternative dose of ZVL (SC) [42], one study compared an alternative dose of ZVL (SC) with placebo [41], one study compared ZVL (SC) with ZVL (IM) [28], one study compared ZVL (SC) to high potency ZVL (SC) [40], and one study compared ZVL (SC) with refrigerated ZVL (SC) [29].",
            "startOffset": 50885,
            "title": "Safety outcomes: Serious adverse events"
        },
        {
            "endOffset": 56395,
            "parents": [],
            "secId": "s0070",
            "sentence": "We were not able to perform NMA for the efficacy outcomes in the \u226550 years old population because age is an effect modifier, age was imbalanced between the studies, and the limited number of available studies made it impractical to control for age.",
            "startOffset": 56147,
            "title": "Discussion"
        },
        {
            "endOffset": 34436,
            "parents": [],
            "refoffsets": {
                "b0035": {
                    "endOffset": 34435,
                    "startOffset": 34430
                },
                "b0040": {
                    "endOffset": 34435,
                    "startOffset": 34430
                }
            },
            "secId": "s0005",
            "sentence": "RZV (Shingrix, GSK) was approved by the Food and Drug Administration (FDA) and Health Canada in October 2017 for prevention of HZ in adults aged 50 years and older [7,8].",
            "startOffset": 34266,
            "title": "Introduction"
        },
        {
            "endOffset": 41341,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "As such, all included trials were examined in terms of covariates which could act as potential treatment effect modifiers.",
            "startOffset": 41219,
            "title": "Network meta-analysis feasibility assessment"
        },
        {
            "endOffset": 52580,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "NMA results"
                }
            ],
            "secId": "s0065",
            "sentence": "For systemic reactions, data were available for the same formulations from the same studies, except ZVL (ID) for which there were no data.",
            "startOffset": 52442,
            "title": "Safety outcomes: Reactogenicity"
        },
        {
            "endOffset": 54849,
            "parents": [],
            "secId": "s0070",
            "sentence": "There were no statistically significant differences between RZV (IM), placebo or any of the ZVL formulations in SAEs (with \u226442 days or longest duration of follow-up).",
            "startOffset": 54683,
            "title": "Discussion"
        },
        {
            "endOffset": 49204,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "NMA results"
                }
            ],
            "secId": "s0055",
            "sentence": "The VE was statistically significantly different between the two vaccines in both age groups as the CI did not include zero.",
            "startOffset": 49080,
            "title": "Efficacy outcomes"
        },
        {
            "endOffset": 52935,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "NMA results"
                }
            ],
            "secId": "s0065",
            "sentence": "There was a statistically significantly higher incidence of injection-site reactions comparing RZV (IM) to refrigerated ZVL (SC) (IRR:2.93; 95% CI 1.24, 6.93), ZVL (SC) (IRR:2.24; 95% CI 1.28, 3.93), ZVL (IM) (IRR:4.23; 95% CI 1.80, 9.98) and placebo (IRR:7.11; 95% CI 4.65, 10.89)).",
            "startOffset": 52652,
            "title": "Safety outcomes: Reactogenicity"
        },
        {
            "endOffset": 39134,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Details of the search strategy are provided in Supplementary File S2.",
            "startOffset": 39065,
            "title": "Systematic literature review"
        },
        {
            "endOffset": 50884,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "NMA results"
                }
            ],
            "refoffsets": {
                "b0045": {
                    "endOffset": 50883,
                    "startOffset": 50877
                },
                "b0050": {
                    "endOffset": 50883,
                    "startOffset": 50877
                }
            },
            "secId": "s0060",
            "sentence": "RZV (IM) was compared with placebo [9,10].",
            "startOffset": 50842,
            "title": "Safety outcomes: Serious adverse events"
        },
        {
            "endOffset": 63978,
            "parents": [],
            "secId": "s0080",
            "sentence": "JEM reports personal fees from the GSK group of companies, during the conduct of the study; and personal fees from Sanofi, Pfizer, Novovax, Medicago and Merck, outside the submitted work.",
            "startOffset": 63791,
            "title": "Conflict of Interest"
        },
        {
            "endOffset": 44888,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "For RZV efficacy, as the vaccine was developed to be administered in a 2-dose schedule, the modified vaccinated cohort was preferred over the total vaccinated cohort, similar to the pre-specified primary endpoint population, to ensure the patients would have received both doses of vaccine.",
            "startOffset": 44598,
            "title": "Network meta-analysis"
        },
        {
            "endOffset": 45864,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "The kappa statistic was 0.61 (good agreement) for the screening of studies from the databases, 0.88 (excellent agreement) for the conference abstracts, and 0.73 (good agreement) for the full-text screening.",
            "startOffset": 45658,
            "title": "Systematic literature review"
        },
        {
            "endOffset": 50057,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "NMA results"
                }
            ],
            "secId": "s0055",
            "sentence": "For HZ in subjects aged \u226560 years, RZV (IM) was statistically significantly better than ZVL (SC) (IRR:0.17; 95% CI 0.11, 0.25) and placebo (IRR:0.08; 95% CI 0.06, 0.12) (Fig. 3a).",
            "startOffset": 49878,
            "title": "Efficacy outcomes"
        },
        {
            "endOffset": 41218,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Transitivity implies that there are no systematic differences between the available comparisons other than the vaccines being examined (i.e. participants in the head-to-head studies included could have been randomized to any of the vaccines).",
            "startOffset": 40976,
            "title": "Network meta-analysis feasibility assessment"
        },
        {
            "endOffset": 51326,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "NMA results"
                }
            ],
            "secId": "s0060",
            "sentence": "Details of the preparations used in each study are summarised in Table 1.",
            "startOffset": 51253,
            "title": "Safety outcomes: Serious adverse events"
        },
        {
            "endOffset": 54215,
            "parents": [],
            "secId": "s0070",
            "sentence": "The VE against HZ of RZV (IM) was 41 percentage points and 54 percentage points higher than the VE of ZVL (SC) in subjects aged \u226560 years and subjects aged \u226570 years, respectively.",
            "startOffset": 54035,
            "title": "Discussion"
        },
        {
            "endOffset": 34265,
            "parents": [],
            "refoffsets": {
                "b0025": {
                    "endOffset": 34150,
                    "startOffset": 34147
                },
                "b0030": {
                    "endOffset": 34264,
                    "startOffset": 34261
                }
            },
            "secId": "s0005",
            "sentence": "Firstly, the Shingles Prevention Study (SPS) which included over 38,000 subjects aged at least 60 years [5] and secondly the Zoster Efficacy and Safety Trial (ZEST) which included over 22,000 subjects aged 50\u201359 years [6].",
            "startOffset": 34043,
            "title": "Introduction"
        },
        {
            "endOffset": 46643,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "Study duration or planned follow-up time in the other 4 studies ranged from 3 to 14 months.",
            "startOffset": 46552,
            "title": "Systematic literature review"
        },
        {
            "endOffset": 56984,
            "parents": [],
            "secId": "s0070",
            "sentence": "The results of the NMA showed a statistically significantly lower incidence of injection-site reactions for refrigerated ZVL (SC), ZVL (SC), ZVL (IM) and placebo, compared with RZV (IM), and there was a statistically significantly lower incidence of systemic reactions for placebo, ZVL (IM), ZVL (SC), refrigerated ZVL (SC), and an alternative dose of ZVL (SC), compared with RZV (IM).",
            "startOffset": 56599,
            "title": "Discussion"
        },
        {
            "endOffset": 41502,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "These were identified a priori and included age, sex, race, follow-up time, interventions and dose schedules, study design and quality, and outcome definitions.",
            "startOffset": 41342,
            "title": "Network meta-analysis feasibility assessment"
        },
        {
            "endOffset": 33448,
            "parents": [],
            "secId": "s0005",
            "sentence": "Other zoster vaccines are available elsewhere in the world.",
            "startOffset": 33389,
            "title": "Introduction"
        },
        {
            "endOffset": 38532,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Safety outcomes included total discontinuations, serious adverse events (SAEs), and reactogenicity (injection site/local reactions [pain, redness and swelling at injection site]; and systemic reactions [fatigue, fever, myalgia, gastrointestinal symptoms and headache]).",
            "startOffset": 38263,
            "title": "Systematic literature review"
        },
        {
            "endOffset": 55957,
            "parents": [],
            "secId": "s0070",
            "sentence": "Additionally, this could be due to the small sample size of patients who developed PHN in the clinical trials, limiting the power to detect differences especially in sub-populations.",
            "startOffset": 55775,
            "title": "Discussion"
        },
        {
            "endOffset": 63288,
            "parents": [],
            "secId": "s0075",
            "sentence": "Although some of the individual studies in the analysis were quite large, the networks for individual outcomes were small, and the results should therefore be interpreted with caution.",
            "startOffset": 63104,
            "title": "Conclusion"
        },
        {
            "endOffset": 40047,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "A kappa statistic was calculated to assess the level of agreement during screening.",
            "startOffset": 39964,
            "title": "Systematic literature review"
        },
        {
            "endOffset": 60119,
            "parents": [],
            "secId": "s0070",
            "sentence": "Tricco et al. indicated that the results comparing PHN efficacy for RZV and ZVL were inconclusive owing to a lack of data; however, in the current frequentist analysis stratified by age, there was enough data to evaluate VE for PHN in all age groups, and IRR for PHN in the \u226560 years of age group.",
            "startOffset": 59822,
            "title": "Discussion"
        },
        {
            "endOffset": 56598,
            "parents": [],
            "secId": "s0070",
            "sentence": "Reactogenicity, as assessed by local injection-site reactions and systemic reactions, was statistically significantly higher with RZV (IM) compared with placebo and most of the ZVL formulations analysed.",
            "startOffset": 56395,
            "title": "Discussion"
        },
        {
            "endOffset": 61723,
            "parents": [],
            "secId": "s0070",
            "sentence": "The underlying studies also have some limitations, as populations recruited for the RCTs may under-represent certain population groups, for example non-white participants.",
            "startOffset": 61552,
            "title": "Discussion"
        },
        {
            "endOffset": 46871,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "Study duration in the other trials ranged from 1 month to 3 months, mainly for safety outcomes.",
            "startOffset": 46776,
            "title": "Systematic literature review"
        },
        {
            "endOffset": 62594,
            "parents": [],
            "secId": "s0075",
            "sentence": "In the absence of head-to-head clinical studies, NMA provides a unique opportunity to evaluate evidence for the comparative efficacy and safety of RZV compared with ZVL, based on currently available published RCTs on the individual vaccines.",
            "startOffset": 62353,
            "title": "Conclusion"
        },
        {
            "endOffset": 41628,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Due to the limited number of studies available, meta-regression could not be conducted for any of the covariates of interest.",
            "startOffset": 41503,
            "title": "Network meta-analysis feasibility assessment"
        },
        {
            "endOffset": 39312,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "In addition, the Cochrane Database of Systematic Reviews was searched for existing SLRs related to clinical efficacy and/or safety and/or reactogenicity of RCTs for HZ vaccines.",
            "startOffset": 39135,
            "title": "Systematic literature review"
        },
        {
            "endOffset": 39690,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Publications were initially screened using title and abstract by two independent researchers.",
            "startOffset": 39597,
            "title": "Systematic literature review"
        },
        {
            "endOffset": 46551,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "Among the 6 trials that evaluated RZV, ZOE-50 and ZOE-70 were phase III trials and had the longest study durations (over 3 years).",
            "startOffset": 46421,
            "title": "Systematic literature review"
        },
        {
            "endOffset": 51731,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "NMA results"
                }
            ],
            "secId": "s0060",
            "sentence": "The NMA for safety outcomes used count data in the regression analyses, so the number of events and the total person-time of follow-up are accounted for in the model.",
            "startOffset": 51565,
            "title": "Safety outcomes: Serious adverse events"
        },
        {
            "endOffset": 58604,
            "parents": [],
            "refoffsets": {
                "b0240": {
                    "endOffset": 58603,
                    "startOffset": 58599
                }
            },
            "secId": "s0070",
            "sentence": "The Comit\u00e9 sur l\u2019immunisation du Qu\u00e9bec (CIQ) recommended that RZV be used preferentially over ZVL [48].",
            "startOffset": 58500,
            "title": "Discussion"
        },
        {
            "endOffset": 47040,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "Results from the assessment of risk of bias are presented in Supplementary File S4.",
            "startOffset": 46957,
            "title": "Systematic literature review"
        },
        {
            "endOffset": 51967,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "NMA results"
                }
            ],
            "secId": "s0065",
            "sentence": "Evidence was available to compare reactogenicity outcomes for RZV (IM) and several formulations and routes of ZVL.",
            "startOffset": 51853,
            "title": "Safety outcomes: Reactogenicity"
        },
        {
            "endOffset": 57897,
            "parents": [],
            "secId": "s0070",
            "sentence": "There were no differences in SAEs between the vaccines.",
            "startOffset": 57842,
            "title": "Discussion"
        },
        {
            "endOffset": 44063,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Frequentist results cannot be interpreted in terms of absolute expected results for each intervention.",
            "startOffset": 43961,
            "title": "Network meta-analysis"
        },
        {
            "endOffset": 36705,
            "parents": [],
            "secId": "s0005",
            "sentence": "While NMAs have been frequently used in other therapeutic areas, the technique has not often been applied to vaccines.",
            "startOffset": 36587,
            "title": "Introduction"
        },
        {
            "endOffset": 46957,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "Key patient and intervention characteristics for each trial are summarised in Table 2.",
            "startOffset": 46871,
            "title": "Systematic literature review"
        },
        {
            "endOffset": 48670,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                },
                {
                    "id": "s0045",
                    "title": "NMA results"
                }
            ],
            "secId": "s0055",
            "sentence": "Fig. 2 shows the NMA results for VE against HZ in subjects aged \u226560 years (Fig. 2a) and aged \u226570 years (Fig. 2b).",
            "startOffset": 48557,
            "title": "Efficacy outcomes"
        },
        {
            "endOffset": 63790,
            "parents": [],
            "secId": "s0080",
            "sentence": "DC, EE, TM and LO also hold shares in the GSK group of companies.",
            "startOffset": 63725,
            "title": "Conflict of Interest"
        },
        {
            "endOffset": 46135,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "Of the 21 trials, 18 were multi-centre and 3 were single-centre.",
            "startOffset": 46071,
            "title": "Systematic literature review"
        }
    ],
    "docId": "S0264410X19304554",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": "ashleigh.a.mcgirr@gsk.com",
                "first": "Ashleigh",
                "initial": "A.",
                "last": "McGirr"
            },
            {
                "email": null,
                "first": "Robyn",
                "initial": "R.",
                "last": "Widenmaier"
            },
            {
                "email": null,
                "first": "Desmond",
                "initial": "D.",
                "last": "Curran"
            },
            {
                "email": null,
                "first": "Emmanuelle",
                "initial": "E.",
                "last": "Espi\u00e9"
            },
            {
                "email": null,
                "first": "Tomas",
                "initial": "T.",
                "last": "Mrkvan"
            },
            {
                "email": null,
                "first": "Lidia",
                "initial": "L.",
                "last": "Oostvogels"
            },
            {
                "email": null,
                "first": "Benedetto",
                "initial": "B.",
                "last": "Simone"
            },
            {
                "email": null,
                "first": "Janet E.",
                "initial": "J.E.",
                "last": "McElhaney"
            },
            {
                "email": null,
                "first": "Heather",
                "initial": "H.",
                "last": "Burnett"
            },
            {
                "email": null,
                "first": "Katrin",
                "initial": "K.",
                "last": "Haeussler"
            },
            {
                "email": null,
                "first": "Adriana",
                "initial": "A.",
                "last": "Thano"
            },
            {
                "email": null,
                "first": "Xuan",
                "initial": "X.",
                "last": "Wang"
            },
            {
                "email": null,
                "first": "Rachel S.",
                "initial": "R.S.",
                "last": "Newson"
            }
        ],
        "doi": "10.1016/j.vaccine.2019.04.014",
        "firstpage": "2896",
        "issn": "0264410X",
        "keywords": [
            "Comparative efficacy",
            "Herpes zoster",
            "Post-herpetic neuralgia",
            "Reactogenicity",
            "Safety",
            "Vaccine"
        ],
        "lastpage": "2909",
        "openaccess": "Full",
        "pub_year": 2019,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "The comparative efficacy and safety of herpes zoster vaccines: A network meta-analysis"
    }
}